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C Ihipta l 
Introduction 
Otitis media is one of the most frequent infectious diseases of early infancy and childhood and 
the most common reason for children to visit a physician ' In the past two decades, there has been 
a substantial worldwide increase in the incidence of otitis media 0 In the USA, acute otitis media 
(AOM) is diagnosed over 5 million times a year and is the most common reason for prescription 
of antibiotics in children 1 This however, results in an increase in resistance to antibiotics Overall 
the costs of controlling this disease has exceeded 3 billion dollars yearly in the USA alone 3 
Otitis media is defined as an inflammation of the middle ear cavity This definition does not 
include references to etiology or pathogenesis ^ Acute otitis media (AOM) is associated with 
a rapid onset of symptoms and signs of acute infection in the middle ear cavity, such as fever, 
otalgia, bulging of the tympanic membrane and purulent discharge (otorrhea), but so far no 
constellation of signs and symptoms has been universally accepted for its definition ^ Otitis 
media with effusion (OME) is the presence of fluid in the middle car cavity without signs and 
symptoms of an acute infection A 
A wide variety of microorganisms has been associated with otitis media, nonetheless detailed 
research has mainly focused on Stteptococcus pneumoniae, Haemophilus mfiuenzae, and 
Moraxella catarihalis as being the major pathogens cultured from middle car effusions69 
Among these bacteria S pneumoniae dominates and plays a leading role in the pathogenesis of 
acute otitis media in children and adults worldwide l0 
The anatomy and the physiology of the middle ear 
The middle ear cavity, is an irregular formed, air filled chamber, located in the temporal bone 
This almost completely closed cavity is connected to the nasopharynx via the eustachian tube 
(ET) It is separated from the external auditory canal by the tympanic membrane Inside this 
cavity, the auditory ossicles form a chain of small bones connecting the tympanic membrane on 
the lateral wall and the oval window on the medial wall Just below the oval window, a membrane 
of connective tissue covers the round window which separates the tympanic cavity from the 
inner ear The tympanic cavity is lined by a mucosa composed of a simple epithelium overlying 
a thin submucosa interspersed with capillaries The mucosa is attached to the penosi " On the 
ventral part of the cavity the epithelium differs from the rest, by being ciliated Here, ciliated and 
secretory cells of the mucosal lining form two distinct tracts that connect the epitympanum with 
the ET These tracts are contiguous with the ciliated part of the epithelial lining of the ET which 
descends into the nasopharynx p Mucus forms a 'micron-thick' blanket overlying the cilia 
Synchronized ciliary movement conveys the mucus towards the nasopharyngeal orofices of the 
ET (mucociliary transport system), carrying with it dead cells from mucosal turnover as well as 
foreign particles such as bacteria and inflammatory products After reaching the nasopharynx 
the mucus is swallowed Adequate functioning of this system depends largely on middle ear 
ventilation which can influence ciliary function as well as characteristics of the mucus 11 Middle 
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ear ventilation and pressure equilibration is maintained through ET functioning The anterior end 
of the tube is in continuity with the nasopharynx and its posterior end is in continuity with the 
middle ear The ET consists of collapsible membranous and membranocartilaginous segments 
and a non-collapsible bony segment (posterior) Muscles contributing to the opening of the ET arc 
attached to the external surface of the dorsal part of the collapsible segments The inner surface 
of the dorsal part of the tube is almost completely lined by squamous epithelium suggesting 
a ventilatory function, while the ventral portion, with its ciliated / secretory epithelial lining 
is equipped for mucociliary clearance l4 Normally the ET is collapsed but during swallowing 
and yawning the tube opens momentarily as a result of muscular activity enabling pressure 
equilibration between tympanic cavity and environment 
Pathogenesis of otitis media 
The pathogenesis of otitis media is considered as being multifactorial Factors involved include 
impaired ET function and immature ET anatomy, viral and bacterial exposure and a deficient 
or immature immune status. In addition, genetic and environmental factors may play a role " 
Particularly ET dysfunction is assumed to play an important role in the development, persistence 
and recurrence of otitis media "'l7 From nasopharyngeal swabs of patients with acute otitis media 
(aged up to 10 years) S pneiimomcie is cultured most frequently.IS In medical microbiology 
S pneumoniae is known as the pneumococcus, referring to its morphology and its involvement 
in pneumonia Pneumococci are transmitted by respiratory droplets that become attached to the 
mucosa followed by colonization of the nasopharyngeal epithelium " It is assumed that under 
certain circumstances these bacteria are translocated from the nasopharynx into the middle ear 
cavity, resulting in otitis media Often a viral infection of the upper respiratory tract precedes 
the development of otitis media Viral induced nasopharyngeal inflammation may cause ET 
dysfunction due to mucosal swelling, impaired mucociliary clearance, accumulation of secretions 
and/or direct mucosal damage A reduced clearance function may facilitate and/or prolong the 
inflammatory response of the middle ear20 Furthermore, a report of Tong et al (2002 ) : | indicates 
that influenza A virus and S pneumoniae infection act synergistically to enhance the exposure 
of specific carbohydrate moieties that act as receptors for S pneumoniae This is one of many 
mechanisms through which virus infections may increase and facilitate pneumococcal invasion 
of the middle ear In addition, it has been shown that direct viral invasion of the middle ear 
results in otitis media : : However, the exact mechanisms involved remain obscure 
Management of otitis media 
Several therapeutic and preventive strategies have been developed for otitis media By now, 
management of otitis media may imply, adenoidcctomy, insertion of tympanostomy tubes, 
antibiotics and vaccination However, a universal and ideal strategy has not yet been found 
As for pneumococcal vaccination, the nonconjugated 23-valent pneumococcal polysaccharide 
vaccines fails to protect children under 2 years of age because pneumococcal polysaccharides 
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are T-cell independent antigens that fail to induce protective immune responses before 2 years of 
age ^ In contrast, the protein-conjugated pneumococcal vaccines, that consist of pneumococcal 
capsular polysaccharides covalently linked to a protein carrier, induce a T-cell-dependcnt 
response that can be evoked already in infancy2Λ In addition, these vaccines induce immunologic 
memory However, pneumococcal conjugate vaccines may in the long temi fail to prevent 
otitis media because of replacement phenomenona > : ! ' 'This implies that after pneumococcal 
vaccination, nasopharyngeal colonization with vaccine types of S pneumoniae will be replaced 
by non-vaccine types that in their tum may cause otitis media Hence, several pneumococcal 
surface proteins are considered to be alternative vaccine candidates because of their serotype-
independence Results from experiments with some of these protein vaccines are promising 
I e. oral immunization with recombinant pneumococcal surface adhesin A (PsaA) has proven 
to be highly protective against colonization with 5 pneumococcal serotypes in mice 2 7 PsaA as 
well as pneumococcal surface protein A (PspA) are able to prevent pneumococcal carriage in 
mice28 and pncumolysin has shown to elicit protection against invasive diseases 1'' However, 
although the results are promising, no evidence is available at the moment that these proteins 
elicit a universal protection against pneumococcal infections Furthermore, it remains unknown 
whether after pneumococcal eradication other bacteria may cause otitis media Not surprisingly, 
also viral vaccines, such as influenza A and B, provide some protection against the development 
of otitis media ," In children between 6 months and 3 years of age, that were given a trivalent 
split-virus influenza vaccine, an overall reduction in the incidence of AOM of 20-30 % has been 
observed " 
Apart from vaccination, there is an ongoing development of alternative therapeutic strategies 
Since the natural route of pneumococcal infections is considered to start with colonization, it 
seems rational to aim at prevention of pneumococcal colonization by using anti-adhesive agents 
To prevent the colonization with 5 pneumoniae as well as with H influenzae, specific sugars that 
were able to block bacterial adherence in vitro have been tested in animal models.12 Sometimes 
a reduction in bacterial colonization could be established, but not all used agents were effective, 
which was ascribed to the fact that a single sugar was used in stead of a cocktail 12 However, 
to be able to compose an adequate cocktail it is necessary to obtain more knowledge about the 
receptors on mucosal epitheha that are used by pneumococci for adherence to the host as well as 
about the regulation of their expression 
Otitis media research: the role of animal models 
In addition to in vitio systems, the use of animals as models for human diseases has proven to 
be indispensable in the understanding of the causes, biology and prevention of diseases such as 
otitis media An intact immune system is one of the advantages of animal models over in vitro 
methods, although this may differ from humans In an experimental setting several variables 
can be controlled, although to a lesser extent than in in vitro conditions Furthermore, repeated 
and successive observations are possible as well as different types of sampling Moreover, when 
inbred specific pathogen free (SPF) strains are used, the immunological status of the animals in 
12 
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an experimental group is almost identical and their bacterial status is known The major drawback 
of animal models in otitis media research is the artificial methods used to induce a middle ear 
infection in otherwise healthy animals, in order to mimic the etiopathogenesis of this disease in 
humans Such methods may imply the direct inoculation of bacteria into the middle ear cavity via 
the tympanic membrane or bulla In current experimental models neither bacterial colonization, 
nor impaired mucosal immune response or other underlying conditions predisposing for otitis 
media in humans are taken into consideration or play a role Furthermore, the majority of the 
studies has been performed in chinchillas, although it has been demonstrated that ET function in 
chinchillas is radically different from that of humans " The rat seems to be more favourable as 
a model for experimental middle ear studies since the macro- and microanatomy of the ET, its 
opening and closure mechanisms included, show better anology with those of humans^ " and 
ET function has been shown to be comparable 1'' "Moreover, the tubal mucosa of the rat bears 
striking similarities to the mucosal lining of the human ET.1" As in chinchillas, the rat tympanic 
membrane is readily accessible for inspection by otomicroscopy and all common pathogens 
associated with otitis media in humans, ι e 5 pneumoniae, H influenzae and M tatuirhalis arc 
also able to induce otitis media in the rat, at least when these bacteria arc inoculated into the 
middle ear3'' 
Induction of otitis media by direct bacterial inoculations into the middle ear is an acceptable 
method as long as the outcome measures of the study are supposed to be independent of the 
way in which the experimental infection is established For instance, the efficacy of antibiotics 
may be established in this way However, none of the current rat models is suitable to study 
the pathogenesis of the natural infection process in otitis media because of interfering pro­
inflammatory mediators resulting from tissue trauma due to inoculation or surgery, or resulting 
from application of biochemical agents Animal models that closely resemble the natural course 
of otitis media in humans are required in studies adressmg immunological as well as pathogenic 
aspects of otitis media, and a realistic model implies infection of the middle ear cavity via the 
ET. Until recently such an animal model for otitis media was not available 
Aim of the study 
Despite the profusion of publications on otitis media, a better understanding of the exact 
pathogenic mechanisms of this disease is required The objective of our investigations was to 
gain further insight in the various pathogenic mechanisms leading to otitis media, with emphasis 
on the role of S pneumoniae, in order to design new therapeutic and /or preventive strategies 
The specific aims of this study were 
to provide evidence for the generally accepted hypothesis that bacteria from the 
nasopharynx actually gain access to the middle cavity, resulting in otitis media, 
to explore a possibility to improve the ET function in order to prevent the development 
of otitis media, 
to determine whether and to what extent an inflammatory response of the middle ear 
depends on the entering agent in order to assess whether only classic otopathogens are 
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specific for the development of otitis media, 
to identify mucosal receptors of the host that are exploited by pneumococci in colonization 
of the nasopharynx, and 
to develop a non-invasive rat model to study the pathogenesis of otitis media 
Outline of the thesis 
In Chapter 2 an overview of the state of the art of otitis media research is presented with 
special emphasis on the pathogenic role of S pneumoniae 
In Chapter 3 a study is presented on the genetic relatcdness of paired pneumococci, 
concurrently derived from middle ear and upper respiratory tract of otitis media 
patients 
In Chapter 4 the effects of transtympamc inoculations of antigenic as well as non-
antigenic substances into the middle car of Lewis rats arc described 
In Chapter 5 the effect of the administration of exogenous surfactant on the ventilatory 
and clearance function of the ET in rats is described 
In Chapter 6 the results of m vivo and in viti υ experiments on the involvement of 
glycosaminoglycans in the adherence of pneumococci to mucosal epithelium are 
presented 
In Chapter 7 the development of a new, non-invasive rat model for otitis media is 
described 




1 FreidVM Mukut DM Rooks RN Ambulatory health tare visits by children principal diagnosis and place of visit Vital 
Health Slat 1998, Π 1-23 
2 Sarrell FM, Cohen HA Kahan E Naturopathic treatment for ear pain in children Pediatrics 2001 111(5 Pi 1) 574-
579 
3 Darrow DM Dash N, Dcrkay CS Onus media concepts and conlroversies Curr Opm Otolaryngol Head Neck Surg 
2003, II 416-23 
4 Blucstone CD Defimlions, terminology, and classification In RM Roscnfeld and CD Blucstone (Lds) E\ idcncc-bascd 
onus media BC Decker Inc. Hamillon-London, 2003 
5 Chan LS, Takata OS. Shekelle Ρ Morton SC Mason W Marcy SM Evidence assessment ot management of acute otitis 
media. II research gaps and priorities tor future research Pediatrics 2001, 108 248-254 
6 Chi Dil, Hcndlcy JO, French Ρ Arango P, Haydcn FG, Winther Β Nasopharyngeal reservoir of bacterial otitis media and 
sinusitis pathogens in adults during wellness and viral respiralory illness Am J Rhinol 2003,17 209-214 
7 Cayc-Thomasen Ρ Tos M Eustachian lube gland tissue changes are related lo bacterial species in acute onus media Ini 
J Pediatr Otorhmolaryngol 2004 68 101-110 
8 Palmu AA Herva E, Savolamcn H, Karma P, Makela PH, Kilpi TM Association of clinical signs and symptoms with 
bacterial findings in acute otitis media Clin Infect Dis 2004, 38 234-242 
9 Lee IIY Andalibi A. Websler P, Moon SK, Tcutcrt K, Kang SH, Li JD, Nagura M Ganz T. Lim DJ Antimicrobial activ ity 
of innate immune molecules against Stfeplococais pncitmomue Mofa\ella calwihtihs and nontypeable Ilacniaphilm 
influenzile BMC Infect Dis 2004,4 1-12 
10 Reinen RR Pneumococcal conjugate vaccines a European perspective Int J Med Microbiol 2004 294 277-294 
11 Junqucira LC CameiroJ Basic Histology Lange Medical Publications, Los Altos, 1983 
12 Mulder JJS, KuijpersW The mucosal lining of the eustachian tube of the rat Acta Otolaryngol 1991 III 342-348 
13 Sade J The middle ear mucociliary system In The eustachian tube Ed J Sade Kugler Publications Amsterdam. 1987 
14 Mulder JJ Kuijpers W Rat eustachian tube and its musculature Ann Otol Rhinol Laryngol 1999.108 277-285 
15 Casselbrant ML, Mandel EM Epidemiology In RM Rosenfeld and CD Blucstone (Eds) Lvidence-bascd otitis media 
BC Decker Inc. Hamilton-London, 2003 
16 Takahashi H llayashiM Sato H, Honjo I Primary deficits m eustachian lube function in patients with otitis media with 
effusion Arch Otolaryngol Head Neck Surg 1989 115 581-584 
17 van Hccrbcck N, Ingels K, Snik A, Zielhuis OA Eustachian tube function in children after the insertion ot ventilation 
tubes Ann Olol Rhinol Laryngol 2000, 110 1141-1146 
18 Nielsen IIU, Konradscn HB LousJ Fnmodt-Mollcr Ν Nasopharyngeal pathogens in children with acule otitis media in 
a low-antibiotic use country Int J Pediatr Otorhmolaryngol 2004,68 1149-1155 
19 Ghaftar I- Fnedland IR McCrackcn GH Dynamics of nasopharyngeal colonization by Slieplmmins pnennmniai PeJ 
InfeaDisJ 1999 IX 638-646 
20 Haydcn FG Influenza virus and rhinovirus-rclaled onus media potential for antiviral intervenlion Vaccine 2000 19 
Suppl 1 S66-S70 
21 Tong IUI, Grants I Liu X DeMaria TF Comparison of alteration of cell surlacc carbohydrates of the chinchilla 
tubotympanum and colonial opacity phenotype of Slieplococcus pneumoniae during experimental pneumococcal otitis 
media with or without an antecedent influenza A virus infection Infect Immun 2002,70 4292^(301 
22 Heikkmen T, Thint M, Chonmailree Τ Prevalence of various respiratory viruses in the middle car during acule onus 
media NEJM 1999,340 260-264 
23 Klein DL Pneumococcal conjugate vaccines review and update Microbial Drug Resistance 1995 I 49-58 
24 Poland GA The burden ol pneumococcal disease the role of conjugate vaccines Vaccine 1999 17 1674-1679 
25 Bogacrt D, Hermans PW, Adrian PV, Rumkc HC, de Groot R Pneumococcal vaccines an update on current strategies 
Vaccine 2004, 22 2209-2220 
26 Ghaffar F, Barton Τ, Lorano J, Muniz LS, Hicks P, Oan V, Ahmad N, McCrackcn GH Jr Fftcct of the 7-valent 
pneumococcal conjugate vaccine on nasopharyngeal colonization by Stieptmoccuspneumoniae in the first 2 years ot 
life Clin Infect Dis 2004, 39 930-938 
27 Seo JY, Seong SY, Ahn BY, Kwon IC, Chung H, Jcong SY Cross-protective immunity ot mice induced by oral 
immuni7ation with pneumococcal surface adhesin a encapsulated in microspheres Infect Immun 2002 70 1143-1149 
28 Brilcs, DE, Ades, E Palon, JC, Sampson. JS, Carlone, GM, Hucbner, RC Virolainen. A. Swiallo F Hollingshcad, SK 
Intranasal immunization ot mice with a mixture of the pneumococcal proteins PsaA and PspA is highly protective against 
nasopharyngeal carnage of Sheptoioiim pneumoniae Infect Immun 2000,68 796-800 
29 Musher D M, Phan, Il M Baughn R L Protection against bactcrcmic pneumococcal infection by antibody to 
pneumolysin J Infect Dis 2001, 183 827-830 
30 Belshe RB Current status of live attenuated influenza virus vaccine in the US Virus Res 2004. 103 177-185 
31 Ruben FL Inaclivaledinfluenzavirusvaecinesinchildren Clin Infect Dis 2004.38 678-688 
32 Sharon N, Ofek I Safe as mothcr\ milk carbohydrates as future anti-adhesion drugs lor bacterial discases Glycoconj J 
2000, 17 659-664 
33 Doyle WJ Eustachian lube function in the chinchilla Arch Otolaiyngol 1985,111 305-308 
15 
Clhiptci 1 
34 Albiin Ν. Hcllslrom S, Salen Β, Stentors LE, Soderberg O The anatomy oflhe eustachian tube in the rat a macro- and 
microscopical study Anat Ree 1983,207 513-521 
35 AlbiinN The anatomy of the Eustachian lube Acta Otolaryngol Suppl 1984,414 34-37 
36 White P, Hcrmansson A. Svinhufvud M Surfactant and isoprcnalinc effect on Eustachian tube opening in rats with acute 
otitis media Am J Otolaryngol 1990,11 389-392 
37 Hamada E, Iwano T, Ushiro K, Tada N, Kinoshila T, Kunwawa Τ Animal model of otitis media with effusion Acta 
Otolaryngol Suppl 1993.500 70-74 
38 Albiin N, Hellslrom S. Stentors LE, Cerne A Middle car mucosa m rats and humans Ann Olol Rhinol Laryngol Suppl 
1986, 126 2-15 
39 Prellner K, Hcrmansson A, While P, Melhus A, Bnlcs D Immunization and protection in pneumococcal otitis media 






C H A P T E R ^ 
Factors contributing to the pathogenesis of otitis 
media, with emphasis on pneumococci 




Objective: To provide a state of the art on otitis media research (particularly OME) with special 
emphasis on the role of Streptococcus pneumoniae in its pathogenesis. 
Study design: A literature review, focussing on the role of Streptococcus pneumoniae, 
pneumococcus-host interactions and biofìhn development. 
Methods: Articles have been selected by MEDLINE search supplemented with a manual 
crosscheck of bibliographies. 
Results: Pathogenic mechanisms in middle ear and eustachian tube are described. Furthermore, 
pneumococcal characteristics and pneumococcal-host interactions are highlighted as well as the 
possible role ofbiofìlms in persistent or recurrent otitis media. 
Conclusions: Due to the availability of new techniques, an increasing number of pneumococcal 
features contributing in the pathogenesis of otitis media are identified. Similarly, comprehensive 
knowledge of pneumococcal-host interactions is increasing. Evidence is growing that biofìlm 
formation may play a major role in the chronicity as well as recurrence of otitis media. This flux 
in research on otitis media opens up new perspectives for therapeutic or preventive strategies. 
20 
Factors contiïbutinu to the pathogenesis of otitis media 
Etiology and pathogenesis of otitis media with effusion 
/nfroducfjon 
Otitis media is a common health problem associated with substantial morbidity and considerable 
health care costs.1 The different stages of otitis media, acute otitis media (AOM) and otitis 
media with effusion (OME) are assumed to be a continuum, as overlaps in pathogenesis and 
histopathologic findings have been observed, suggesting that one type of otitis media may 
change into another.2 Hence, for a clinician it is difficult to assess the precise stage of the patients 
illness accurately, especially after the acute symptoms have decreased. Chronic OME seems to 
be a common complication of AOM in which persistence of middle ear fluid has been observed 
for more than 3 months.'The precise etiology and pathogenesis of otitis media are not clear, but 
multiple factors appear to play a role including anatomic abnormalities resulting in eustachian 
tube (ET) dysfunction, environmental factors like exposure to cigarette smoke and community-
acquired respiratory pathogens (both viral and bacterial), and circumstances like a history of 
gastroesophageal reflux, crowding and day care attendence as well as immature or impaired 
immunological status."1 ·' Considering the role of the ET dysfunction several theories have been 
postulated, that will be discussed later. When it comes to the role of microorganisms, the most 
common bacterial pathogens involved are Streptococcus pneumoniae, Haemophilus influenzae 
and Moraxella catarrhalis. In addition, respiratory viruses like influenza A and respiratory 
syncytial virus (RSV) play an important role.56 A study to assess the efficacy of an intranasal 
influenza vaccine, containing influenza A and influenza Β strains, indicated that influenza 
vaccination contributes to a reduction of AOM.7 Bacterial vaccine strategics, aimed to prevent 
otitis media directly or to reduce nasopharyngeal bacterial carriage, diminishing the likelihood of 
the development of AOM are currently investigated.8'' Among these vaccines against the major 
pathogens S. pneumoniae received the most attention. After somewhat disappointing results 
with a 23-valent pneumococcal polysaccharide vaccine, that failed to protect children under two 
years of age,9 a new class of pneumococcal conjugate vaccines seemed be a good alternative, 
since these showed protection against AOM caused by pneumococcal serotypes included in the 
vaccine1". In addition, a reduction in serotype-specific pneumococcal nasopharyngeal carriage 
was demonstrated." However, more recent studies indicate an increase in emergence of otitis 
media induced by non-vaccine serotype in vaccinated children.12 Furthermore, an increase in 
AOM caused by H. influenzae and M. catarrhalis has been reported.1" "This indicates that the 
efficacy of conjugate vaccines is limited due to replacement disease. For this reason, alternative 
strategies to prevent otitis media by bacteria like S. pneumoniae have to be explored and will be 
described in this article. 
Dysfunctional and immature eustachian tube function 
In 1867 Politzer published the hydrops 'ex vacuo' theory14, postulating that impairment of the 
ET function is involved in the development of otitis media. Impaired ventilation function, due to 
either physical obstruction or fai lure to open results in underpressure since gasscs in the middle car 
21 
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cavity are absorbed but not replaced Consequently, a sterile transudate effusion originating from 
the blood vessels in the mucosal lining starts to fill the tympanic cavity Besides ET dysfunction 
it is now known that bacteria as well as viruses arc involved too " ' These observations affect the 
Pohtzer-theory, although some of its elements can still be maintained The term "dysfunctional" 
not only refers to ET opening failure, but also to closing failure (patulous tube), or to a tube 
that opens too easily due to a low resistance (semipatulous tube) It is conceivable that via 
a patulous or semipatulous tube nasopharyngeal pathogens may gain access to the tympanic 
cavity, since this duct is the only connection with the external environment, ι e the nasopharynx 
Indeed, identical pneumococcal genotypes in nasopharynx and middle ear effusion within single 
patients, have been demonstrated during otitis media '^  Moreover, microbial intrusion of the 
ET itself may lead to impaired clearance function, due to the adverse effect of viruses, bacteria 
and bacterial products on the ciliary function of the respiratory epithelial lining 16 17This may 
also lead to the accumulation of mucus and blockage of the ET resulting in a negative middle 
ear pressure, and to accumulation of transudate in the tympanic cavity The accumulating fluid 
may then serve as a source of nutrients for pathogens thereby facilitating proliferation l s "This 
leads to a viscious circle because bacterial intrusion (S pneumoniae, H influenza, as well as M 
catarrhalis) increases goblet cell density in ET and middle ear cavity which further enhances 
mucus production sustaining the pathologic process Ultimately, this may result in excessive 
mucus secretion for up to at least six months, although some degree of progress towards 
normalization usually occurs following the first two weeks after the onset of otitis media lü 
During early childhood ET function is not optimal because of the anatomy of infants and young 
children At older age, ET function gradually improves due to the growth of the craniofacial 
skeleton, ultimately leading to an adequately functioning of the ET in post-puberty21 The 
inadequate ET function combined with a still immature and sometimes compromised immune 
system implying a weak local antimicrobial defence system in the young child, may facilitate the 
access of microorganisms to the middle car as reflected by the high prevalence of otitis media 
in infants and toddlers." Among child care center attendees, about 50% to 60% of the children 
were found to have an asymptomatic middle-ear effusion at some time during a year follow-up, 
with a peak incidence during the winter months In school-aged children this incidence decreased 
to 25% 21 
Streptococcus pneumoniae 
Bacterial characteristics 
Encapsulated strains of S pneumonia are among the principal contributors to otitis media in 
infants and children 141s In addition, they are major pathogens causing pneumonia and invasive 
disease like bacteremia and meningitis :6 
S pneumoniae (pneumococcus) is a facultative anaerobic, oval or spherical gram-positive 
coccus that usually grows in pairs (diplococcus) or in short chains From its outermost surface 
moving inwards the envelope of S pneumoniae consists of a polysaccharide capsule, a cell 
wall consisting of polysaccharides and proteins with usually large amounts of teichoic acids 
->-> 
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and a plasma membrane consisting of a lipid bilayer with numerous proteins Transformation 
from a capsulated into an unencapsulated phenotype is possible 17 The capsular volume, as well 
as its composition vary considerably28 Polysaccharide capsules protect pneumococci against 
phagocytosis, by interfering with the binding of complement factor C3b to the pneumococcal 
cell surface Therefore, the capsule is an important virulence factor enabling the bacterium 
to survive and to proliferate within tissues followed by tissue damage in the infected host ,8 
29
 Over 90 pneumococcal serotypes have been identified, based on differences in capsular 
polysaccharide composition In fact, less than 30 serotypes account for the majority (>90%) 
of invasive diseases10 while the amount of most frequently isolated pneumococcal serotypes 
from middle ear effusions is only 15 ^ Pneumococci are distributed among the world population 
clustered in groups of varying serotypes Worldwide, the prevalence of different serotypes may 
vary per geographic area1'' and age group," while there is also a seasonal influence^ Apart 
from serotype differences, Weiser et al (1994)" demonstrated that pneumococci display an 
interchangeable colonial morphology opaque and transparant Transparant variants were found 
to express more teichoic acid and less capsular polysaccharide while opaque variants contain 
less teichoic acid and more capsular polysaccharide :,6 These morphological differences are 
associated with a different interaction of the pncumococcus with its host Transparant variants 
demonstrate an increased ability to adhere while opaque variants are more potent inducers of 
inflammation ,7 In vivo, populations of pneumococci are heterogeneous mixtures of opaque and 
transparant organisms that are present concurrently 
Unlike certain other pathogens like Staphylococcus aureus Corynebactei mm diphthenae, 
Escherichia coll and Clostridium difficile, S pneumoniae produces relative few exotoxins 
Disease is predominantly caused because of replication within host tissucs,s and the subsequent 
inflammatory response The host responds to cell wall components such as (lipo)teichoic acids 
that arc released after bacteriolysis19 18 and to pncumolysin that is released from the cytoplasm 
during bacterial growth and lysis M In addition, certain proteins or enzymes displayed on the 
surface of pneumococci may contribute to the pathogenesis and disease symptoms (Table 1) 
Genetic plasticity plays a central role in the biology of the pncumococcus S pneumoniae has 
the ability to adopt DNA from other pneumococcal serotypes as well as from related species 
present in the same ecological niche (e g oral streptococci) Capsular types can be switched 
through intraspecies transformation, while interspecies transformation is responsible for the 
rapid emergence of antibiotic resistance A clone of S pneumoniae may evolve from low-level to 
higher-level penicillin resistance by uptake of penicillin-binding protein gene fragments from the 
nonencapsulated streptococci Streptococcus oralis and Stieptococcus mitis, that serve as donors 
of resistance genes These bacteria are considered to be sources of mutated DNA sequences 
which code for penicillin binding proteins ""'47 
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Degradation of hyaluronan and chondroitin 
Facilitates generation of inflammatory response 
Activated when biosynthesis stops 
Mediates cell lysis and release of virulence factors 
(c g pneumolysin, cell wall components) 
Functions not yet clear Cleaves the terminal portion of sialic 
acid of the target cells May reveal surface receptors lor 
possible pneumococcal 
interactions 
Manganese transporter for 5 pneumoniae 
Manganese regulates the expression of other 
virulence factors 
Associated with adhesion and virulence 
Altered PBPs are responsible for resistance against 
ß-lactam after pbp-gene mutations 









The nasopharynx of normal, healthy children is recurrently colonized for different periods 
of time by a variety of bacterial strains 4I< Apparently, these bacteria resist local host defence 
mechanisms such as the flow of secretions that constantly washes the mucosal surfaces 
Colonization of the nasopharynx starts soon after birtlv19 by strains currently circulating in the 
community and includes commensal, aerobic (α-haemolytic vindans streptococci) and anaerobic 
(Peptostreptotottm anaerobms) organisms as well as potential pathogens (5 pneumoniae, 
H influenzae M catarrhalis) , ϋ As for S pneumoniae carriage rates are particularly high in 
infants and young children M ^ A gradual decrease is seen with age, finally resulting in carriage 
rates in adolescents that are similar to those found in adults" 
Colonization by pathogens in the presence of a resident flora requires strategies enabling a 
successful competition for nutritional and spatial resources and displacement of commensal 
organisms from the microbial niche The presence of commensals like vindans streptococci 
protect against settlement of pathogens as they display interfering potential by the production of 
antagonistic substances like bactenocins and hydrogen peroxide Ml , 4 This has been demonstrated 
in a double blind, randomised, placebo-controlled study in which a solution of a-haemolytic 
streptococci was sprayed into the nose twice daily for 10 days These a-haemolytic streptococci 
showed the ability to inhibit the growth of common pathogens and were capable of a significant 
reduction in the recurrence rate of acute otitis media during three months " 
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Prevalence of bactericidal microorganisms increases with advancing age for unknown reasons 
suggesting that bacterial interference may be one of the mechanisms that accounts for the greater 
resistance of adults to streptococcal throat infections when compared to children S6 In contrast to 
adults, in which interactions between the endogenous microflora and exogenous pathogens often 
are decided in favour of the endogenous florae7 95 -100% of the children is colonized at least 
once by potential pathogens in the first year of life ,8 For this reason, regulation of the microflora 
composition (e g by probiotics) offers the possibility to influence prevention and treatment of 
disease 
Adherence 
The initial event in pneumococcal colonization is the attachment of the pneumococcus to the 
mucosal surface Macromolecular components on the bacterial surface, called adhcsins, arc 
essential for withstanding mechanical removal because they enable bacterial attachment to 
host cell receptors, which is a prerequisite for colonization ,9 In its most simple form, bacterial 
adherence or attachment to a host cell requires an adhesin and a receptor In respiratory epithelia 
pneumococcal receptors usually are carbohydrate or peptide residues on the host cell surface 
Evidence for adherence of S pneumoniae to human resting lung cells and nonactivated human 
tracheal epithelial cells via carbohydrate sequences of glycohpid receptors has been presented ',n 
62
 Inflammatory stimuli, for instance after viral infection, rapidly activate epithelial cells and 
modulate the expression of surface receptors As a result, additional receptors become available 
for the pneumococcus In vitro, a 50% increase in pneumococcal adherence was observed after 
lung cells were activated experimentally This was associated with the appearance of a new 
carbohydrate receptor and of the platelet-activating factor (PAF) receptor61 Viral activation 
of epithelial cells by respiratory viruses like rhinovirus, influenza virus and RSV also leads to 
expression of PAF-receptors and an increase of the number of adhering pneumococci61 M As for 
influenza viruses, Peltola et al (2004)6'1 demonstrated neuraminidase activity to be responsible for 
the increase in pneumococcal adherence due to exposure of additional pneumococcal receptors 
on host cells Supplementary studies are required to identify the mechanisms that influence 
pneumococcus-host interactions after infections with respiratory viruses that lack neuraminidase 
activity 
Until recently, it was unknown whether S pneumoniae also utilizes proteoglycans (PGs) to 
adhere to host cells. PGs are macromolecules composed of a protein core with covalently linked 
glycosaminoglycan (GAG) side chains GAGs are negatively charged polysaccharides composed 
of alternating residues of amino sugars and uronic acids. GAGs of physiological significance are 
heparin, heparan sulfate, chondroitin sulfate, dermatan sulfate and hyaluronan '* Because of their 
wide distribution and direct accessibility it is not surprising that many pathogens have evolved 
mechanisms to exploit PGs for attachment. Adherence is achieved through bacterial adhesins 
that recognize specific GAGs 67 Especially heparan sulfate6" 69 but also dermatansulfate70 and 
/ or chondroitin sulfate arc used as microbial receptors 71 A first study adressing the role of 
GAGs in pneumococcal adherence indicates that these carbohydrates are indeed involved in 
pneumococcal binding ^ Given its genomic plasticity, it is likely that S pneumoniae utilizes 
2S 
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different glycoconjugate receptors for adherence 
Mucosal host response 
Over the last decade, it has become evident that binding between a microorganism and a host cell 
initiates processes in both the host cell and the bacterium Binding of bacteria may facilitate the 
action of bacterial toxins or invasins,71 while in the host cell binding may induce cell signaling 
and the release of mediators, such as cytokines ^ 
After pneumococcal binding to the mucosal surface the increase in mucociliary clearance and the 
production of antimicrobial molecules such as lysozym, lactofemn, peroxidases and antimicrobial 
peptides like p-defensins^ contribute to the nonimmunological host defence Lactofemn exerts 
a bacteriostatic effect that is based on its iron binding property,7'' while lysozyme inhibits the 
growth of pathogens by inducing ultrastructural damage 77 ß-Defensins display broad spectrum 
antimicrobial activity under physiological conditions and contain the ability to kill both gram-
positive and gram-negative bacteria, fungi, eukaryotic parasites and enveloped viruses 7I< 
Pneumococcal binding to mucosal receptors also induces a specific immune response Follicular 
lymphocytes present in Waldeyer's ring in man, or in the lateral pharyngeal and tubal bands 
in rodents initiate the production of IgG, IgM as well as IgA.79 80 IgA is not only produced 
in these specific lymphoid tissues but also by plasma cells that are scattered in the mucosal 
lamina propria and are considered to provide an internal mucosal barrier beneath the mucosal 
epithelium Through a specific receptor mediated transport mechanism, translocation of IgA into 
the nasopharyngeal secretions will occur as secretory IgA (slgA) A supplementary secretory 
polypeptide component prevents the antibody from proteolytic degradation Binding of slgA to 
microbes thwarts bacterial attachment to, or penetration into the mucosal surface 8| Nasopharynx 
as well as ET and tympanic cavity are capable of mounting a mucosal immune response against 
microbial agents, as can be deduced from the presence of secretory IgA in middle ear fluids 
and IgA secreting cells discovered in the mucosal linings in the upper respiratory region and 
the middle car*10 Although IgA certainly is the major mucosal immunoglobulin, other classes of 
antibodies are present as well K 
Despite the various defence mechanisms of the host, pneumococci are still able to colonize the 
nasopharynx Although pneumococcal carriage of the nasopharyx is usually asymptomatic, it is 
nevertheless related to both development of disease and spread of the pathogen in the community 
Why potential pathogens, after a longer or shorter symptom-free period of colonization, 
transform into bacteria that trigger inflammatory responses, invade adjacent tissues and even 
sometimes the bloodstream, remains unknown In the gastro-intcstinal tract, metabolic stress 
induced by a chemical stressor was shown to lead to an inflammation of the enteric epithelium 
by its microflora 81 Metabolic stress resulted in a loss of epithelial barrier function, increased 
penetration of bacteria into the mucosa, and increased synthesis of proinflammatory cytokines 
Experiments using animal models demonstrated that various types of psychological and physical 
stress also induce dysfunction of the intestinal barrier84 With respect to the respiratory tract 
it is known that health conditions like allergy and viral infections, as well as the effects of 
smoking and airborne environmental pollutants, may play a role in the susceptibility to bacterial 
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infection ^ It is conceivable that in nasopharyngeal epithelium stress factors are also involved in 
the disturbance of the bactenum-host equilibrium, initiating a sequence of events that may lead 
to otitis media 
Mucosal bioülms 
Up to 62% of the children suffer at least one episode of AOM during the first year of life 86 
Recurrent acute otitis media occurs during the first years of life in approximately 20 to 30% of 
the pediatric population of the United States "Antibiotic therapy for acute otitis media has been 
recommended as a standard in the United States and other countries for many decades Persistent 
otitis media, characterized by persistence of symptoms and signs of middle ear infection during 
antimicrobial therapy (treatment failure) and/or relapse of acute otitis media within 1 month of 
completion of antibiotic therapy are often observed " Persistence of otitis media in children and 
the recalcitrance to antibiotics displays analogy with antibiotic-resistant chronic lung infections 
in patients with cystic fibrosis, which is attributed to the presence of a biofilm (Pseudomonas 
aeruginosa) in the lungs 88 Hence it was postulated that OME could be a biofilm disease as 
well89 Biofilms are defined as organized communities of (mixed) microorganisms enclosed in 
a self-produced polymeric matrix attached to an inert or a living surface Biofilms constitute a 
protected mode of growth which prevails in the majority of the total bacterial biomass present 
in animal and human bodies, as well as in the environment Antibodies are not effective in 
killing bacteria within biofilms Additionally, biofilms arc impermeable for antibiotics. Biofilm 
infections arc rarely resolved by host defence mechanisms Dispersion of biofilm bacteria is 
possible through the breaking-off of biofilm fragments while active biofilm-induccd processes 
due to e g nutrient depletion or waste product accumulation may lead to the release of single 
cells or aggregates of cells. Subsequently, released bacterial aggregates or planktonic bacteria 
may settle and start the formation of a new biofilm '*1 
Post et al (1995)'" observed that bacteria could be cultured from the majority of middle ear 
effusions of patients experiencing an episode of acute otitis media (which is mostly sclf-
limiting) while only 28.9% of the effusions of patients with chronic otitis media were culture-
positive However, when testing the effusions of these chronic patients by PCR, 77 3% of the 
specimens proved to be positive for one or more microorganisms In effusions of OME patients 
tested for the presence of pneumococci both by culture and PCR, 11% of the samples were 
found to be culture positive while in 46% pneumococcal DNA was detected 9 :In addition, the 
presence of bacterial mRNA (short-lived and necessary for DNA transcription) was detected in 
a significant percentage of culture-negative middle ear effusions, establishing the presence of 
viable, metabolically active, intact organisms in some culture-negative effusions 91 The fact that 
cultivable bacteria seem to be largely absent in effusions of chronic patients, while nonetheless 
both bacterial DNA and mRNA can be detected, is indicative of the presence of a biofilm in 
the tympanic cavity The rapid recurrence of OME after antibiotic treatment reinforces this 
assumption However, only indirect evidence for the presence of a biofilm in OME patients is 
available at present The reason is that analysis of a small mucosal biopsy or partly removed 
mucosal lining is not conclusive, since the location of the presumed biofilm in the tympanic 
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cavity is unknown Nonetheless, the results of a recent experimental animal study supports the 
biofilm hypothesis After intratympanic inoculation of// influenzae in chinchillas the formation 
of bacterial biofilms on middle-ear mucosae could be demonstrated directly9"1 Since the whole 
bullae of the chinchillas were removed it was possible to study the complete mucosal linings of 
the affected ears In humans, the presence of bacterial biofilms has been detected in the majority 
of a number of cholesteatomas that were surgically removed One of the characteristic features 
of cholesteatomas is that they are often accompanied by chronic or recurrent infections that 
are highly resistant to eradication by topical and systemic antimicrobial agents ^ Furthermore, 
biofilm formation has been observed on grommets of children with OME from whom the 
tympanostomy tubes were removed after recurrent post-tympanostomy otorrhea96 However, in 
spite of increasing evidence, conclusive proof for the presence of biofilms in OME patients has 
yet to be established 
Concluding remarks 
The state of the art on otitis media opens up new perspectives for therapeutic or preventive 
strategies Because of the multifactorial origin of otitis media, it is not likely that just one, 
comprehensive therapy will resolve this disease. However, future viral vaccines, e g against 
RSV, may reduce the incidence of AOM Furthermore, pneumococcal proteins like PsaA,''7 
PspA,98 ΡρρΑ,Η pneumolysin " o r combinations of these may be promising candidates for future 
vaccine startegies, owing to their serotype-independence However, potential pitfalls may be 
the subsequent pneumococcal replacement at the nasopharyngeal level by other pathogens such 
as Η influenzae and M catarrhahs, again resulting in otitis media 10 " Apart from vaccination, 
probiotics may offer new perpectives, since a reduction of pathogenic nasopharyngeal colonization 
has been reported after consumption of probiotic, fermented milk lon Additionally, consistent 
use of a nasal spray with α-hemolytic streptococci proved to reduce the recurrence of AOM ^ 
Novel therapeutic stategies that prevent or disrupt the adhesion of potential pathogens like S 
pneumoniae to nasopharyngeal epithelial cells, permitting efficient removal by mucociliary 
clearance, may offer a potential adjunct or even alternative to antibiotic therapy 
Thorough knowledge of for instance pneumococcal adherence may lead to new strategies to 
prevent or combat pneumococcal carriage which may reduce pneumococcal disease itself as 
well as horizontal spread of pneumococcal strains and biofilm formation Since pneumococcal 
adherence to mucosal epithelia may be blocked by receptor analogs and pneumococci have 
shown to utilize carbohydrates from glycolipids and PCs as receptors, as has been shown for 
H influenzae,"" suitable receptor analogs may be carbohydrates that are structurally identical 
to those of glycolipids i n : and PGs, respectively Hence, to realize anti-adhesive therapies the 
development of appropriate cocktails of inhibitory sugars and GAGs may be promising 
Animal models to assess the efficacy (of a combination) of these strategics arc required for the 
exploration of novel intervention strategics in otitis media 
28 
Factor <> contributing to the pathogenesis οίοι it is media 
References 
1 Rovers MM, Schilder AG. ZielhuisGA. Rosenfeld RM Otitis media Lancet 2004.363.465-473. 
2 Yoon TH, Paparella MM, Schachern PA, Lmdgren BR Morphometnc studies of the continuum of otitis media Ann Otol 
Laryngol Suppl Rhinol 1990:148· 23-27 
3 Blucstonc CD Definitions, terminology and classification In Roscnfcld RM, Bluestonc CD, eds Evidem e-hused onus 
media Hamilton BC Decker. 1999 X5-I03 
4 Straetcmans M, van Ileerbeek N, Tonnaer E, Ingcls KJ, Rijkers GT, Ziclhuis GA A comprehensive model for Ihe aetiology 
of otitis media with effusion Med Hypotheses 2001, 57 784-791 
5 Ruuskanen 0, Arola M, Pulto-Launla A, Mensola J, Meurman O. Viljanen MK. Halonen Ρ Acute otitis media and 
respiratory virus infections Pediatr Infect Dis J 1989; 8 94-99 
6 Heikkinen T. Thint M . Chonmaitrcc Τ Prevalence of Various Respiratory Viruses in the Middle Lar during Acute Otitis 
Media Ν Engl J Med 1999: 340 260-264 
7 Bclshc RB. Current status of live attenuated influenza virus vaccine in the US Virus Res 2004. 103. 177-185 
8 Green BA, Zhang Y, Masi AW.ct al PppA, a surface-exposed protein of Sireplococcm pneumoniae, elicits cross-reactive 
antibodies that reduce colonization in a murine intranasal immunization and challenge model Infect Immun 2005. 73 981 -
989. 
9 Bogaert D, Hermans PW, Adrian PV, Rumkc HC, de Groot R Pneumococcal vaccines an update on current strategics 
Vaccine 2004; 22 2209-2220 
10 Eskola J, Kilpi T, Palmu A, et al Efficacy of a pneumococcal conjugate vaccine against acute otitis media Ν Fngl J Med 
2001; 344·403-409 
11 Mbcllc N, Hucbncr RE, Wasas AD, Kimura A, Chang I, Klugman KP Immunogcmcity and impact on nasopharyngeal 
carriage of a nonavalent pneumococcal conjugate vaccine J Infect Dis 1999, 180 1171-1176 
12. Russell F, Mulholland Κ. Prevention of otitis media by vaccination Drugs 2002.62 1441-1445 
13. Kilpi T, Ahman H, Jokmen J. et al Protective efficacy of a second pneumococcal conjugate vaccine against pneumococcal 
acute otitis media in infants and children· randomized, controlled trial of a 7-\ aient pneumococcal polysaccharide-
meningococcal outer membrane protein complex conjugate vaccine in 1666 children Clin Infecl Dis 2003. 37 1155-
1164 
14 Politzer A Diagnose und Therapie der Ansammlung seröser Flüssigkeit in der Trommelhohle Wien Med Wochcnschr 
1867. 17 244-247. 
15 Tonnaer EL, Rijkers GT, Mcis JF, Klaasscn CH, Bogaert D, Hermans PW, Curfs JH. Genetic relationship between 
pneumococcal populations originating from nasopharynx, adenoid and tympanic cavity in children with otitis media 
(J Clin Microbiol, accepted 2005) 
16 Ohashi Y, Nakai Y Current concept of mucociliary dysfunction in otitis media with effusion Acta Otolaryngol (Stockh) 
1991; Suppl 486· 149-161 
17 Park K, Bakaletz LO, Coticchia JM, Lim DJ · Effect of influenza A virus on ciliary activity and dye transport function in the 
chinchilla eustachian tube Ann Otol Rhinol Laryngol 1993,102 551-558 
18 Buchman CA, Dylc WJ, Skoner D, Fireman P, Gwaltney JM Otologic manifestations of experimental rhinovirus infection 
Laryngoscope 1994,104 1295-1299 
19. Jcckcr P, Pabsl R, Westermann J The mucosa of the middle car and eustachian lube in Ihe young rat number of 
granulocytes, macrophages, dendritic cells, NK cells and Τ and Β lymphocytes in healthy animals and during otitis media 
Acta Ololaryngol 1996,116.443-450. 
20. Cayc-Thomascn P, Tos M Eustachian lube gland tissue changes arc related lo bacterial species in acute otitis media Int J 
Pediatr Otorhinolaryngol 2004, 68 101-110 
21 Kemaloglu YK, Goksu N, Ozbilcn S, Akyildiz Ν Otitis media with effusion and craniofacial analysis-II "Mastoid-middle 
car-custachian tube system" in children with secretory otitis media Int J Pediatr Olorhinolaryngol 1995, 32 69-76 
22 Jero J, Karma P. Bacteriological findings and persistence of middle car effusion m otitis media with effusion Acta 
Otolaryngol Suppl 1997,529-22-26 
23 Rosenfeld RM, Culpepper L, Doyle KJ, et al Clinical practice guideline otitis media wilh effusion Otolaryngol Head Neck 
Surg 2004, 130 S95-SI18. 
24. Sato K, Liebeler CL, Quartey MK, Le CT. Giebink GS Middle car fluid cytokine and inflammatory cell kmclics in ihe 
chinchilla otitis media model. Infecl Immun 1999, 67. 1943-1946 
25. Slenfors LE, Raisanen S Quantitative analysis of the bacterial findings in otitis media J Laryngol Olol 1990: 104 749-
757. 
26 Onhucla CJ, Gao G, Francis KP, Yu J, Tuomanen EI Tissue-specific contributions of pneumococcal virulence factors to 
pathogenesis. J Infecl Dis 2004.190.1661-1669 
27 Arrccubieta C, Lopez R, Garcia E. Molecular characterization of cap3A, a gene from the Operon required for the synthesis 
of the capsule of Sneplococcus pneumoniae type 3 sequencing ofmulations responsible for the unencapsulated phenotype 
and localization of ihe capsular cluster on the pneumococcal chromosome J Bactenol 1994, 176 6375-6383 
28 TomaszA Surface components of Slreploc oc cm pneumoniae Rev Infect Dis 1981,3 190-211 
29 van den Dobbelsteen GPJM Mucosal immune response to pneumococcal polysaccharides in the rat 77;c.ws Utrecht. The 
Netherlands; 1994 
29 
C hapt er 2 
30 Marlens Ρ Worm SW Lundgrcn Β Konradsen IIB Benfielcl Τ Serolypc-spccific mortality trom invasive Slicplocoiiiit 
pmiimomcie disease revisited BMC Infect Dis 2004,4 21-28 
31 Hausdorff WP Yothers G Dagan R, et al Multinational study of pneumococcal serotypes causing acute otitis media in 
children Pedialr Infect Dis J 2002,21 1008-1016 
32 Muhlcmann Κ Matter HC Tauber MG Bodmer Τ Nationwide surveillance of nasopharyngeal Slieplococcus pneumoniae 
isolates trom children with respiratory infection Switzerland 1998-1999 J Infect Dis 2003,187 589-596 
33 Bogaert D van Belkum A Sluijter M el al Colonisation by Stieptotocciis pneumoniae and Slapfalmoiim aniens in 
healthy children Lancet 2004 363 1871-1872 
34 SuhkowskaA, Grzesiowski Ρ SadowyE FiettJ llrymewiczW CharacXcnfMa ofSlreplocnccifipneumoniae Haemophilus 
mflmnzai and Moi axella catanhalu isolated from the nasopharynges of asymptomatic children and molecular analysis of 
S pneumoniae ζηά Η influenzae strain replacement in the nasopharynx J Clin Microbiol 2004 42 3942-3949 
35 Weiser JN Austrian R, Srccmvasan PK, Masure HR Phase variation in pneumococcal opacity relationship between 
colonial morphology and nasopharyngeal colonization Infect Immun 1994,62 2582-2589 
36 Kim JO, Romcro-Stemer S Sorcnscn UB, et al Relationship belween cell surface carbohydrates and intrastram variation 
on opsonophagocytosis of Stieptococcus pneumoniae Infect Immun 1999 67 2327-2333 
37 Long JP, Tong HH, Shannon PA DeMaria TF Differential expression of cytokine genes and inducible nitric oxide synthase 
induced by opacily phenolype variants of Stieptococcus pneumoniae during acute otitis media in the rat Infect Immun 
2003 71 5531 5540 
38 Sprccr A, Lis A, Gerber J Reinert RR, EifTcrt H, Nau R Differences in clinical manifestation otStuptmmcuïpneumoniae 
infection are not correlated with in vitro production and release of the virulence factors pneumolysin and hpoleichoic and 
leichoic acids J Clin Microbiol 2004, 42 3342-3345 
39 Gmsburg 1 Role of lipoteichoic acid in infection and inflammation Lancet Infect Dis 2002 2 171-179 
40 Rigden DJ Jedrzejas MJ Structures of Streptococcus pneumoniae hyaluronatc lyase in complex with chondroitin and 
chondroitin sulfate disacchandes Insights into specificity and mechanism of action J Biol Chem 2003 278 50596-
50606 
41 Whatmore AM Dowson CG The autolysin-cncoding gene (hlA) of Su eplot ou in pneumoniae displays restricted allelic 
variation despite localized recombination events with genes of pneumococcal bacteriophage encoding cell wall lytic 
enzymes Infect Immun 1999,67 4551-4556 
42 Jedrzejas MJ Pneumococcal Virulence Factors Structure and Function Microbiol Mol Biol Rev 2001,65 187-207 
43 Paton JC Novel pneumococcal surface proteins role in virulence and vaccine potential Trends Microbiol 1998 6 85-
87 
44 Gossink KK, Mann ER Guglielmo C Tuomanen LI Masure HR Role of novel choline binding proteins in virulence of 
Sneplococciis pneumoniae Infect Immun 2000 68 5690-5695 
45 Hiramatsu Κ Ohama M Mijajima Y, et al Antimicrobial susceptibilities and analysis of genes related to penicillin or 
macrolidc resistance m Slieplococc us pneumoniae Ini J Anlimicrob Agents 2004,24 125-129 
46 Clavcrys JP, Prudhomme M Morlier-Bamere I, Martin Β Adaptation to the environment Sii eptoi οι < us pneumoniae a 
paradigm for recombination-mediated genetic plasticity ' Mol Microbiol 2000 35 251-259 
47 Hauser C, Acbi S Muhlcmann Κ An internationally spread clone of Sneptococcus pneumoniae evolves from low 
level to higher-level penicillin resistance by uptake of pcnicillin-bmdmg protein gene fragments from noncncapsulatcd 
pneumococci Anlimicrob Agents Chemother 2004, 48 3563 3566 
48 Faden H, Dufly L Williams A, Kryslofik DA Wolf J Epidemiology of nasopharyngeal colonization with nontypable 
Haemophilus influenzae in the first 2 years of life J Infect Dis 1995, 172 132-135 
49 Principi Ν, Marchisio Ρ Schito GC Mannelli S Risk factors for carriage of respiratory pathogens in the nasopharynx of 
healthy children Pediatr Infect Dis J 1999,18 517-523 
50 Brookl Bacterial inlerference Cm Rev Miciohiol 1999 25 155-172 
51 Leibcrman A, Dagan R, Lcibovit? E.Yagupsky P, Hiss DM The bacteriology oflhe nasopharynx in childhood Int J Pedialr 
Otorhinolaryngol 1999 49 S15I-S153-
52 Bernstein JM Reddy MS Scannapieco FA, Faden HS, Ballow M The microbial ecology and immunology of the adenoid 
Implications for otitis media Ann NY Acad Sci 1997,830 19-31 
53 Borer A Meirson H, Peled N, Poral Ν Dagan R Fraser D, Gilad J Zchavi Ν Yagupsky Ρ Antibiotic-resistant pneumococci 
carried by young children do not appear to disseminate to adult members of a closed community Clin Infect Dis 2001 33 
436-444 
54 Tano Κ Grahn-Hakansson L Holm SL Hellslrom S Inhibition of OM pathogens by alpha-hemolytic streptococci from 
healthy children, children with SOM and children with rAOM Im J Pedialr Otorhinolaryngol 2000 56 185-190 
55 Roos Κ Hakansson EG Holm S Effect of recolonisation with interfering alpha streptococci on recurrences of acute and 
secretory otitis media in children randomised placebo controlled trial BMJ 2001 322 210-212 
56 Sanders CC Nelson GE Sanders WE jr Bacterial interference Epidemiological determinants of the antagonistic activity 
of the normal throat flora against group A streptococci Infect Immun 1977 16 599-603 
57 Tlaskalova-IIogenova II Stepankova R lludeovic Τ et al Commensal bacteria (normal microflora), mucosal immunity 
and chronic inflammatory and autoimmune diseases Immunol Lett 2004 93 97-108 
58 Vives M Garcia ME Saenz Ρ Mora MA Mata L Sabharwal Η SvanborgC Nasopharyngeal colonization in Costa Rican 
children during the first year of life Pediatr Infect Dis J 1997 16 852-858 
59 WizemannTM Adamou JF Langermann S Adhcsins as targets for vaccine development Emcrg Infect Dis 1999 5 396-
30 
tjctors contiibuting io thepjlhogcnc^is ot otitis medu 
403 
60 Krivan HC. Roberts DD, Cnnsburg V Many pulmonary pathogenic bacteria bind speufitally to the carbohydrate sequence 
GalNAc beta I -4Gal found in some glycolipids Proc Nail Acad Sci USA 1988,85 6157-6161 
61 Cundcll D Masure HR, Tuomanen EI The molecular basis of pneumotoccal infection a hypothesis Clin Infect Dis 1995, 
21 Suppl3 S204-211 
62 Andersson B, Dahmen J, Frejd T, Lcfflcr H Magnussen G, Noon G, Eden CS Identification ofan active disaccharide unit of 
a glycoconjugatc receptor for pneumococu attaching to human pharyngeal epithelial cells J Exp Med 1983 158 559-70 
63 McCullers JA, Rehg JE Lethal synergism between influenza virus and Stieplocotim pneumoniae characterization of a 
mouse model and the role of platelet-activating factor receptor J Infect Dis 2002 186 341 -350 
64 Ishizuka S, Yamaya M Suzuki T, Takahashi II, Ida S, Sasaki T, Inouc D Sekizawa Κ Nishimura II Sasaki Η Effects of 
rhinovirus infection on the adherence of Slieptaiottia pneumoniae to cultured human airway epithelial cells J Infect Dis 
2003, 12 1928-1939 
65 Pellold, VT, McCullers, JA Respiratory viruses predisposing to bacterial infections role of neuraminidase Pcdiatr Infect 
Dis J 2004, 23 S87 S97 
66 Ueno M, Yamada S, Zako M Bemfield M, Sugahara Κ Structural characterization of heparan sulfate and chondroitin 
sulfate of syndecan-1 purified from normal murine mammary gland epithelial cells Common phosphorylalion of xylose and 
differential sulfation of galaclose in the protein linkage region lelrasacchande sequence J Biol Chcm 2001 276 29134-
29140 
67 Menozzi FD, Pethe K, Bifam P, Soncin F, Brcnnan MJ Locht C Enhanced bacterial virulence through exploitation of host 
glycosaminoglycans Mol Microbiol 2002,43 1379-1386 
68 Alvarez-Dommgucz C, Vazqucz-Boland JA, Carrasco-Mann E, Lopcz-Mato P, Lcyva-Cobian F Host cell heparan sulfate 
proteoglycans mediate attachment and entry of Lis/ei ia nwnoc Diogenes, and the listcnal surface protein ActA is involved in 
heparan sulfate receptor recognition Infect Immun 1997,65 78-88 
69 Wuppermann FN Hegcmann JH, Jantos CA Heparan sulfale-hkc glycosaminoglycan is a cellular receptor for ( hluimdw 
pneumoniae JInfetl Dis 2001 184 181-187 
70 Frick IM, Schmidtchen A, Sjobrmg U Interactions between M proteins oÎSlieploLoaus p\ ogenes and glycosaminoglycans 
promote bacterial adhesion to host cells Fur J Biochem 2003 270 2303-2311 
71 Almeida RA Fang W, Oliver SP Adherence and internalization of Slieplococcus iibens to bovine mammary epithelial cells 
are mediated by host cell proteoglycans FEMS Microbiol Lett 1999,177 313-317 
72 Tonnaer EL, I lafmans TG. van Kuppcvcll TH, Sanders EA Verweij PE CurfsJH Involvement of glycosaminoglycans m 
the attachment of pneumococu to nasopharyngeal epithelial cells ("submitted; 
73 I ledges S, Agace W, Svanborg C Epithelial cytokine responses and mucosal cytokine networks Trends Microbiol 1995 
3 266-270 
74 Ycllon RF Doyle WJ, Whiteside TL Diven WF, March AR, Fireman Ρ Cytokines immunoglobulins and bacterial pathogens 
in middle ear effusions Arch Otolaryngol Head Neck Surg 1995,121 865-869 
75 Vancikova Ζ Mucosal immunity - Basic principles, ontogeny, cyclic fibrosis and mucosal vaccination Curr Drug Targets 
Immune Endocr Mctabol Disord 2002, 2 83-95 
76 Orsi Ν The antimicrobial activity of lactoferrm current status and perspectives Biomelals 2004.17 189-196 
77 Lee HY, Andalibi A, Webster Ρ el al Antimicrobial activity of innate immune molecules against Siieptococcus pneumoniae 
Moi axella calai ιhalis and nontypeable Haemophilus influenzae BMC Infect Dis 2004.4 12-24 
78 Claeys S, De Belder Τ The role ot mucosal epithelium in antigen presentation Int J Pediatr Otorhinolaryngol 2003 67 
Suppl 1 S77-79 
79 llarabuchi Y, Hamamoto M, Kodama II, Kalaura A Spontaneous immunoglobulin production by adenoidal and tonsillar 
lymphocytes in relation to age and otitis media with effusion Ini J Pediatr Otorhinolaryngol 1996, 35 117-125 
80 Russell MW, Martin Mil, Wu 1I-Y, Hollmgshead SK Moldoveanu Z, Mestccky J Strategics of immunization against 
mucosal infections Vaccine 2000, 19 Suppl 1,SI22-S127 
81 Lamm ME Interaction of antigens and antibodies at mucosal surfaces Annu Rev Microbiol 1997,51 311-340 
82 Mogi G, Macda S, Walanabe Ν The development of mucosal immunity in guinea pig middle ears Int J Pediatr 
Otorhinolaryngol 1980 I 331-349 
83 Nazli A, Yang PC, Jury J,ctal Epithclia under metabolic stress perceive commensal baclena as a threat Am J Pathol 2004, 
164 947-57 
84 Soderholm JD, Yang PC, Ccpoms P, Vohra A, Riddell R Sherman PM, Perdue Mil Chronic stress induces mast cell-
dependent bacterial adherence and initiates mucosal inflammation in rat intestine Gastroenlerology 2002, 123 1099-
1008 
85 Cappelletty D Microbiology of bacterial respiratory infections Pcdiatr Infect Dis J 1998 17 (8 Suppl) S55-61 
86 Tccle DW, Klein JO Rosncr Β Epidemiology of otitis media dunng the first seven years of lite in children in greater 
Boston a prospective, cohort study J Infect Dis 1989, 160 83-94 
87 Pichichero ME Recurrent and persistent otitis media Fed Infect Dis J 2000 19 911-916 
88 May TB, Shinabarger D. Maharaj R, et al Alginate synthesis by Pseudomonas aemginosa a key pathogenic factor in 
chrome pulmonary infections of cystic fibrosis patients Clin Microbiol Rev 1991 4 191-206 
89 Costerton JW Cystic fibrosis pathogenesis and the role of biofilms in persistent infection Trends Microbiol 2001,9 50-
52 
90 Costerton JW, Stewart PS, Greenberg EP Bacterial biofilms a common cause of persistent infections Science 1999 
C h apici 2 
284 1318-1322 
91 Post JC Preslon RA, Aul JJ, et al Molecular analysis of bacterial palhogens in otitis media with effubion JAM A 1995, 
273 1598-1604 
92 Jero J Virolainen A Salo Ρ Leinonen M Fskola J, Karma Ρ PCR assay for detecting Slieplmoccus pnewnomae in the 
middle ear of children with otitis media with effusion Acta Otolaryngol 1996, 116 288-292 
93 Rayner MG, Zhang Y Goiry MC, Chen Y , Post JC, Fhrlich GD Evidence of bacterial metabolic activity in culture-
negative otitis media with effusion JAMA 1998,279 296-299 
94 Ehrlich GD, Vcch R, Wang X. et al Mucosal biofilm formation on middle-car mucosa in the chinchilla model of otitis 
media JAMA 2002.287 1710-1715 
95 Cholc RA, Faddis BT Evidence for microbial biofilms in cholesteatomas Arch Otolaryngol Head Neck Surg 2002, 128 
1129-1133 
96 Post JC Direct evidence of bacterial biofihns in otitis media Laryngoscope 2001,111 2083-2094 
97 ArcasAP, Oliveira ML, Miyaji EN Leite LC. Aires KA DiasWO.HoPL Expression and charactcnzalionofcholera toxin 
B-pneumococcal surface adhesin A fusion protein m Esihenchia coll ability of CTB-PsaA to induce humoral immune 
response in mice Biochem Biophys Res Commun 2004 321 192-196 
98 Bnles DE Protection of the elderly from pneumococcal pneumonia with a protein-based vaccine'' Meth Ageing Dcv 
2004,125 129-131 
99 Ogunniyi AD, Folland RL, Bnles DE, Hollingshcad SK, Paton JC Immunization of mice with combinations of pneumototcal 
virulence proteins elicits enhanced protection against challenge with Stieptococcu* pneumoniae Infect Immun 2000, 68 
3028-3033 
100 Gluck U, Gebbers JO Ingested probiotics reduce nasal colonization with pathogenic bacteria (Staphilotoccm aiiiem 
Stieptocoicus pneumoniae, and bela-hemolylic streptococci) AmJCl inNutr 2003,77 517-520 
101 Noel GJ, Love DC, Mosser DM I Iigh-molccular-wcight proteins of nonlypeable//««ηορΑ/Λη influenzae mediate bacterial 
adhesion to cellular proteoglycans Infect Immun 1994,62 4028-4033 
102 Ofek 1, Hasty DL, Sharon Ν Anti-adhesion therapy ofbaclcrial diseases prospects and problems FEMS Immunol Med 
Microbiol 2003,38 181-191 
32 





Genetic relationship between pneumococcal 
populations originating from nasopharynx, adenoid 
and tympanic cavity in children with otitis media 
Edith L. Tonnacr, Ger T. Rijkers, Jacques F. Meis, Come H. Klaassen, 
Debby Bogaert, Peter W. Hermans, Jo H. Curfs 
J Clin Microbiol, accepted in 2005 
C lhìpti.1 3 
Abstract 
Previous studies have shown that Sfieptococ cui pneumoniae exists m both middle car effusions 
and the upper respiratory region from children with otitis media with effusion (OME), but it 
remains unclear whether these strains represent genetically identical clones Therefore, it cannot 
be determined whether these bacteria originate from a common source 
To determine the presence of pneumococci at different anatomical locations of OME patients, 
conventional culture and PCR techniques were used To analyse a possible genetic relatedness 
between pneumococci from different anatomical sites molecular typing by Amplified Fragment-
Length Polymorphism was applied 
The percentage of middle ear effusions of OME patients being positive for pneumococci after 
PCR analysis (13%) was higher than after conventional culture (5%) Molecular fingerprints 
from pneumococci derived from 2 different anatomical sites within patients were very similar m 
80% of OME patients and m 90% ofAOM patients, indicating their genetic relatedness 
Biofìlm formation or pneumococcal L-forms probably play a role m OME, as culture negative 
effusions prove to contain pneumococcal DNA Bacteria involved m this process most likely 
originate from the nasopharynx as they show a close genetic relatedness with their nasopharyngeal 
counterparts 
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Introduction 
Streptococcus pneumoniae, a major gram-positive human pathogen, is the most common cause of 
meningitis, sepsis and middle cannfections in children, and of pneumonia in immunocompromised 
and elderly individuals As antibiotic resistance has become a worldwide problem, which limits 
the choice of antimicrobial agents, prevention of pneumococcal diseases has become of great 
interest However, despite major advances in the development of pneumococcal polysaccharide 
as well as pneumococcal conjugate vaccines leading to a reduction of invasive disorders', 
eradication of pneumococcal diseases is not within easy reach More and more it seems likely 
that current vaccines will lack efficacy in the long term due to the genomic plasticity of the 
pneumococcus (e g capsular serotype transformation, interspecies transformation by uptake of 
pneumococcal DNA as well as DNA of related species in the same ecological niche)"' and to 
serotype replacement These facts prompt for further research into the yet unknown mechanisms 
of the pathogenesis of pneumococcal disease aiming at the postulation of new therapeutic and 
preventive strategies1 
Regarding the role of pneumococci in the pathogenesis of otitis media, reports are rather 
ambiguous Although pneumococci usually dominate in the bacterial mix present in middle ear 
effusions during acute otitis media (AOM)6, until recently the majority of middle ear effusions 
in otitis media with effusion (OME) appeared to be culture negative 7 In The predominance of 
negative culture results has led to the hypothesis that OME results from an inflammatory response 
induced by residual bacterial metabolites subsequent to AOM" However, the introduction of 
new molecular techniques with significantly improved detection rates did show that in effusions 
that were negative by culture, bacterial DNA was present originating from often more than 
one bacterial species (eg Haemophilus influenzae Stieptococcus pneumoniae Moiaxella 
catarrhalis) p " 
In addition to the identification of these pathogenic strains in middle ear effusions of children 
with otitis media S pneumoniae, H influenzae and M catanhalis could also be cultured from 
the oropharynxN, adenoid1^ and nasopharynx l6 Apparently, the upper respiratory region is an 
ideal habitat for these bacteria Moreover, it has been demonstrated that samples, simultaneously 
obtained from middle ear and nasopharynx from one patient, sometimes contained identical 
bacterial strains or serotypes From this it was concluded that microorganisms from the nasopharynx 
had entered the tympanic cavity via the eustachian tube (ET) However, this conclusion seems 
somewhat preliminary as it was not tested whether two different or two identical bacterial clones 
were involved, while isolates with the same serotype (and the same antibiotic resistance pattern) 
may yield different genotypic patterns17 The value of this conclusion will certainly enhance if a 
genetic relatedness between the bacterial populations from both locations can be determined 
Therefore, the aim of the present study was to investigate in a group of children with OME, 
whether there is a genetic relatedness between pneumococci originating from middle ear, adenoid 
and/or oropharynx As a reference, also a group of children with acute otitis media was selected 
for this study 
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Materials and Methods 
Pa f ƒ en is 
OME 
For this study 178 children (age between 2 and 8 years) were recruited from a population 
enrolled in a larger, randomised trial in which 6 hospitals participated. The selected children 
were the complete study groups of two participating hospitals, localized in the city of Nijmegen. 
In the trial the efficacy of two therapies for recurrent OME was compared. Half of the children 
was treated with ventilation tubes only, while the remaining received a 7- valent pneumococcal 
conjugate vaccine 21-28 days prior to insertion of the tubes (Wyeth Lederle Vaccines, Pearl 
River, NY). 
AOM 
In addition, 15 AOM patients (age between 1-7 years) were randomly recruited from a group of 
children with positive cultures from middle ear effusions and nasopharynx. They belonged to a 
control group enrolled in a larger, randomised double-blind study, aimed to determine whether 
pneumococcal vaccination prevents recurrence of AOM in children with previous episodes of 
AOM (3). All children had experienced at least two episodes of acute otitis media during the 
year before recruitment. One half of the group already had ventilation tubes. The control group 
received hepatitis A (Havrix juniorR, GlaxoSmithKline, Zeist, The Netherlands) or hepatitis Β 
(Engerix-BR, GlaxoSmithKline, Zeist, The Netherlands) vaccinations. 
For both the AOM and the OME-study, written parental informed consent was obtained before 
inclusion in the study. Both study protocols were approved by the appropriate medical ethics 
committees. 
Collection and analysis of samples 
In the OME study, samples from middle ear fluid (aspirated if present), oropharynx (swab) and 
adenoid biopsy were obtained during anaesthesia for insertion of ventilation tubes. All samples 
were plated within 6 hrs onto two 5% Columbia blood agar plates, a 5% Columbia blood agar 
plate with 5 mg/L gcntamicin, and a chocolate agar plate. Agar plates were incubated at 370C for 
48 h; the blood agar plates aerobically and anaerobically, the blood agar plate with gentamicin 
and the chocolate agar plate with raised CO, (5%). Identification of bacterial strains was based 
on colony morphology and conventional methods of determination. When 5. pneumoniae 
was isolated a single colony was picked up for further analysis by immunological scrotyping 
(Quellung reaction with commercially available antisera [Statcns Seruminstitut, Copenhagen, 
Denmark]). Whenever pneumococci were simultaneously recovered from two or three locations 
(oropharynx / adenoid / middle ear effusion), molecular typing was performed and used for 
genotypic comparison. 
In the AOM study, bacterial culture from middle car fluid was obtained at the time of the first 
AOM episode occurring at least 1 month after the last vaccination. After clinical confirmation 
of the diagnosis of AOM, middle ear fluid was collected by myringotomy or by spontaneous 
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drainage near the perforation site with an aspirator or a sterile dry cotton-wool swab. In addition, 
nasopharyngeal samples were obtained with a flexible, sterile, dry cotton-wool swab. Samples 
were processed as described above. For the present study, 15 children with positive pneumococcal 
cultures both from middle car effusion and from nasopharynx were selected and molecular typing 
was performed. 
Detection of pneumococcal DMA by lytA PCR 
DNA was isolated from 90 μΐ of middle ear effusion using a MagNA Pure automated DNA 
extraction platform (Roche Diagnostics, Almere, The Netherlands) as recommended by the 
manufacturer. Detection of the autolysin gene was performed by a real-time PCR assay targeting 
the lytA gene using primers and probes described by McAvin et al.18 
Appropriate positive and negative controls were used. To check for the presence of PCR 
inhibitors that may compromise the amplification reaction, an exogenous DNA target was added 
to the specimens prior to DNA extraction. This artificial DNA construct also served to verify 
proper functioning of all reagents and equipment. This target was amplified in a separate PCR 
reaction. 
Molecular typing by Amplified Fragment-Length Polymorphism (AFLP) 
DNA was isolated from colonies using a MagNA Pure automated DNA extraction platform. 
Prior to extraction, cells were incubated with 50 U of Mutanolysin (Sigma-Aldrich, Zwijndrecht, 
The Netherlands) for 15 min at 37° C. AFLP analyses were performed according to established 
protocols|t)::11 using the restriction enzyme combination £coRI and Ms el (Wcstburg, Leusden, 
The Netherlands). For amplification, a fluorescein labelled EcoRl primer without extensions 
and a Msel primer extended with a G residue were used. Obtained amplification products 
were analyzed on a McgaBACE automated DNA analysis platform (Amersham Biosciences, 
Roosendaal, The Netherlands) using conditions recommended by the manufacturer. 
Fingerprint patterns were analyzed for similarity using Gel Compar II software (Applied Maths, 
Kortrijk, Belgium). Cluster analysis was performed by UPGM using the Pearson correlation 
coefficient, expressed as percentage of similarity. Strains were considered to be clonally related 
if proven more than 90% identical. 
Results 
Bacterial culture 
Samples for pneumococcal culture were collected from 178 children with OME. In the samples 
of 110 children with OME (62%) growth of pneumococci in the standard culture assay was 
detected, distributed over 1, 2 or 3 samples per patients. From only a minority (5%) of children 
with OME S. pneumoniae could be cultured from middle ear effusions. Results are summarized 
in a table (Table I). 
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TABLE Τ Number of culture-positive samples OMF patient, distributed o\er respective lot-ilions. represented in percentages 
of the total amount of children wnh positive pneumococcal cultures 
Niunbcr of eultuic-posiiive PercentHge of Cluldien 
samples, palienl 
Γι oui total study pioiip With geneticallj lelaled 
SÏUIiplcS 
1 ϋιορΙιπίΛΐΐλ οι iiasophamix 6^ 
2 Oropharynx - nasopharynx S9 80 (2) 
(one paticiil nasophaivnx - middle car fluid) 
? Oiupharviix - nasoplirti>iL\ ^ middle eai Ihnd ? 60 (3) 
PCR 
Middle ear effusions were tested by lytA PCR for the presence of pneumococcal DNA. As fluid 
could not be collected from all patients at the moment of insertion of ventilation tubes, not all 
ears were tested. A total of 165 middle ear effusions was analysed. Results of PCR analysis and 
corresponding pneumococcal culture have been summarized in a table (Table II). 
In total, pneumococcal DNA could be detected in 21 samples (13%). All AOM samples were 
. PCR positive, as was expected because 
TABLE II. Prcbeiux of piieiunococci m middle ear llmds as ι tfogy
 w e r c
 culture positive. Positive and 
detected by staudaul eulnue and PCR. lepiescnled in ' 
percentages of the total number of émisions that were analyzed | negative Controls yielded positive and 
. . . , I negative PCR results, respectively. The 
Petcentageof Staiidaid culmie PCR ! a v •> 
effusions I results also indicated that there was 
10 N e
°
a , l v c Posi,lve
 no evidence for PCR-inhibitors in the 
3 Positive Positive 
87 Negative Negative | Samples (not shown). 
AFLP 
AFLP-results arc depicted in the dendrograms of Fig. 1. (This figure also includes the results of 
serotyping.) Per anatomical site one molecular pneumococcal fingerprint was obtained. These 
were compared to assess their genetic rclatedness. 
Dendrogram IB is based on a comparison of fingerprints from all pneumococcal isolates 
belonging to the AOM study group. Dendrogram 1A is based on a comparison of fingerprints 
from a representative, at random selection of pneumococcal isolates belonging to the OME group 
(the dendrogram based on all isolates of the OME group is too large to be reproduced on one 
page). The undermentioned percentages, however, are derived from the complete dendrogram. 
In 60% of the children with OME from which pneumococcal isolates were available derived from 
3 locations within one patient (adenoid, oropharynx and middle ear fluid), the degree of genetic 
relatedness between pneumococcal isolates per patient indicated a clonal origin. In the group of 
OME children from which pneumococcal samples were derived from 2 locations (adenoid and 
oropharynx) clonal relatedness between paired pneumococcal isolates per patient was observed 
in 80% of the children. 
In the group of AOM children, almost 90% of the paired pneumococcal fingerprints per patient 
(derived from nasopharynx and middle ear effusion) showed a clonal origin. 
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Fig.l. Genetic rclatedness between pneumococcal isolates from different locations within 
one patient and between patients, based on AFLP fingerprints The scale bar 
indicates the percentage of similarity 
( 1 A) A random selection of samples ot OME patients 
(IB) Samples of AOM patients Serotypes per sample are included. 




Dendrograms, resulting from AFLP fingerprint analysis demonstrate that pneumococcal 
genotypes per patient have a strong resemblance in 80% of all OME patients when paired samples 
per patient are compared. Furthermore, 90% of the paired pneumococcal samples from AOM 
patients show similarity. A comparison of serotyping and genotyping of paired pneumococcal 
samples of AOM patients démontrâtes that identical serotypes correspond with similar genetic 
fingerprints. However, identical serotypes of paired pneumococcal samples derived from OME 
children not always display homogeneous fingerprint patterns. Identical serotypes demonstrating 
heterogeneous genotypes are frequently observed in pneumococci as these bacteria have the 
genetic capacity to switch serotype. Moreover, transfer of genes between strains is possible21. 
Since OME is a chronic disease, the period between onset and sampling is much longer than in 
AOM, hence it is plausible that serotype switch and/or gene transfer becomes evident especially 
in OME. Genotypic similarity, as was found in the majority of the paired samples, indicates clonal 
relatedness and implicates that pneumococci present at different sites in the upper respiratory 
region of a patient originate from one single source. Most likely this pneumococcal source is 
located in nasopharynx or throat, as these zones are open to the external environment. These 
sites are easily colonized by bacteria and include the orifices of the ETs that are localized at 
both sides in the nasopharynx. It is conceivable that in spite of the protective mechanisms that 
are present in the ET, bacteria may be able to migrate from the nasopharynx into the middle 
ear cavity under specific conditions (e.g. pressure differences between nasopharynx and middle 
ear cavity, immature or compromised immune system), subsequently leading to otitis media. 
This assumption is strengthened especially by the observation of clonal relatedness between 
pneumococci present in nasopharynx and middle ear in 90% of AOM patients. 
In pneumococcal samples obtained from a minority of patients different fingerprint patterns 
were found from different locations within one patient, which indicates that these pneumococci 
are not genetically related. An explanation for this can be found in the method. Although most 
children are colonized by several pneumococcal serotypes34, only a single colony from each 
culture was selected for further analysis, because it was considered highly likely that this one 
will represent the most prevalent serotype in the pneumococcal population at that location. 
Obviously, the more colonies are tested, the better the diversity of the pneumococcal population 
can be explored, but to achieve statistical significance this approach will be extremely time-
consuming and expensive, i.e. as the most uncommon serotype represents only 5% of the total 
pneumococcal population, at least 59 colonies from each sample will have to be serotyped to 
obtain 95% probability of collecting the second pneumococcal type"". 
Remarkable arc the differences between AOM and OME patients. 21% of AOM effusions 
was culture positive for pneumococci', while in OME this percentage was only 5%. This may 
reflect AOM to be an active inflammatory process and OME a chronic disease. Comparison of 
fingerprints from nasopharyngeal pneumococci and middle ear pneumococci from one patient 
showed clonal relatedness in 90% of AOM patients. However, when pneumococcal fingerprints 
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of OME children were compared (isolated from NAS, ORO and MEF), clonal relationship 
was observed in 60% of the children. This may indicate that in AOM patients pneumococcal 
translocation via the ET has occurred recently, while in OME patients pneumococcal passage 
may have taken place a longer time ago. During that period the nasopharyngeal pneumococcal 
population may have changed, which may affect the degree of clonal relatcdness. 
Both conventional bacterial culture and lytA PCR were applied in the present study to establish 
the presence of pneumococci in middle ear fluids of children with OME. PCR analysis revealed 
a higher percentage of positive middle ear effusions (13%) than expected by pneumococcal 
culture (5%), which is in line with the results of Pereira et aP . However, Post et al.12 assessed a 
higher percentage of pneumococcal positive effusions by PCR (29.9%), although the percentage 
determined by conventional culture was similar (5%). This discrepancy may be due to a 
difference in PCR target. Post and coworkers applied a PCR method targeting penicillin binding 
protein gene 2B (PBP2B). Given the fact that horizontal transfer of PBP genes may occur from 
pneumococci to viridans group streptococci present in the same niche^, a PCR targeting the 
PBP2B gene may lead to the amplification of putative pneumococcal sequences, resulting in 
false-positivity, whereas the lytA PCR method is of proven specificity2". 
Observations of negative or minor bacterial growth by culture, despite considerable amounts 
of bacterial DNA in effusions of OME patients, may be indicative of the presence of biofilms. 
Recently, it has been shown that bacterial biofilms were formed on the middle car mucosae of 
chinchillas subsequent to experimental induction of otitis media by H. influenzae1''2''. In addition, 
biofilms were found to be present on tympanostomy tubes derived from OME patients27. These 
observations strongly indicate that biofilm formation may play a role in the pathogenesis of 
OME. In that case it is quite likely that only bacteria released from the biofilm are detected by 
culture. 
Minor bacterial growth in middle ear effusions of OME patients may also be explained by 
the concept described by Domingue et al.28, illustrating that bacteria exposed to a deleterious 
environment (i.e. host defence) can change into L-forms, that persist in a latent state within 
the host, causing pathological responses. These bacteria will not be detected by conventional 
culture methods because L-forms do not form colonies under standard culture conditions. PCR 
may offer an alternative for culture analysis, although a drawback of this technique is that the 
nature of the identified DNA remains uncertain, as DNA of both live and dead bacteria may 
be amplified by PCR. However, from a study of Post et al.29 it can be concluded that DNA in 
effusions originates from live bacteria, as they have demonstrated that DNA from nonviable 
bacteria lacks persistence in middle car effusions of chinchillas. Additionally, bacterial mRNA 
was identified in culture negative middle ear effusions of children with OME,1" which indicates 
the presence of viable, metabolically active, intact organisms, since bacterial mRNA has a very 
short half-life (several seconds to minutes). To establish whether bacterial L-forms or biofilm 
bacteria are involved in OME, mucosal biopsies from several locations in the tympanic cavity 
are required, which for medical ethical reasons cannot be obtained from patients with OME 
only. 
Although the exact bacterial modus vivendi remains unclear, this study shows that pneumococci 
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in middle ear effusions of OME and AOM patients most likely originate from the nasopharynx, 
as they show close genetic relatedness with their nasopharyngeal counterparts. 
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Chapter 4 
Abstract 
Objectives: The observations that during otitis media many different types of microorganisms 
have been cultured from effusions indicate that, once present in the middle ear cavity, most 
types of microorganisms are able to trigger an inflammatory reaction leading to otitis media. 
The present study was designed to determine the middle ear response after injection of'different 
substances into the middle car cavity. 
Study design: To determine whether, and to what extent an inflammatory response of the 
middle ear depends on the entering agent, the response in the tympanic cavity was studied by 
otomicroscopy and histology after inoculation of various substances. 
Methods: Lewis rats were inoculated in transtympanic fashion either with live or heat-killed 
bacteria (pathogenic and non-pathogenic), Keyhole limpet hemocyanin (KLH), active charcoal 
or saline. The mucosal response of the challenged middle ears was studied histologically. 
Results: Irrespective of the inoculated substance no essential differences in the mucosal response 
were found. The intensity of the inflammatory response was greater when live bacteria were 
inoculated. 
Conclusion: The present study demonstrates that any substance reaching the middle car cavity is 
likely to induce otitis media. These observations emphasize the role of the ET as "porte d 'entree" 
in the pathogenesis of this disorder. Determination of specific aspects of the ET involved in 
protection, or in facilitating bacterial translocation, will be important for the understanding of the 
pathogenesis of otitis media and the subsequent development of new therapeutic strategics. In 
addition, elucidation of bacterial factors involved in the process of colonization and translocation 
will be of equal importance. 
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Introduction 
Otitis media, an inflammation of the middle ear cavity, is a very common disease in childhood, 
which may take an acute or chronic course Generally, it is assumed that microbes are able 
to enter the middle ear under specific conditions subsequent to a period of nasopharyngeal 
colonization and retrograde ascension via the eustachian tube (ET)1 Despite the wide varieties in 
microorganisms that have been related to otitis media, detailed investigations have focussed on 
Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis as major middle 
ear pathogens2 A reason for this may be the high incidence of these bacteria in middle car 
effusions in which some seven pneumococcal serotypes often dominate ' In recent investigations, 
several pathogenic properties of these microbes have been determined J 6 In addition, aberrations 
of the immune response of the host towards these microorganisms have been found 7 ^ However, 
some skepticism might be justified For instance, as far as pneumococci are concerned in otitis 
media it might be somewhat short-sighted to focus on only seven pneumococcal types Such a 
well-defined group of seven types does not exist, as variations over time, geographic areas and 
age groups have been demonstrated within the most prevalent capsular pneumococcal types 
isolated from middle ear effusions 7 Even per tested effusion, different types of pneumococcal 
strains can be found in varying numbers,10 although some overlap of serotypes may exist, as 
indicated in a recent annual update " For example, within a certain period the most common 
pneumococcal serotypes isolated in Greece were 6, 9, 23, 14 and 19, while in Finland the most 
frequent serotypes associated with acute otitis media in ranking order were 19F, 23F, 6A, 6B, 
14, 11 and 19A 
Furthennore, the different types of microorganisms, in addition to Streptococcus, Haemophilus 
and Moraxella, that have been cultured from effusions during otitis media include encapsulated 
as well as non-encapsulated bacteria,12 viruses'3 and yeasts l 4 This may indicate that under specific 
conditions microbiological properties, host factors, or interactions between pathogens enable 
microorganisms to enter the middle ear cavity Once there, a wide variety of microorganisms 
seems to be able to trigger an inflammatory reaction resulting in the development of otitis 
media 
The present study was designed to determine whether and to what extent an inflammatory 
response of the middle ear depends on the entering agent Different species and strains of vital 
as well as dead bacteria were inoculated through the tympanic membrane of the rat and followed 
by an analysis of the mucosal response of the middle ear In addition, the effects of antigenic as 
well as non-antigemc (inert) substances were studied in a similar way 
Materials and Methods 
Animals and experimental conditions 
Thirty-five female pathogen-free rats, Lewis strain (Charles River, Someren, the Netherlands) 
(4 weeks of age) were used Seven experimental groups were made, each group consisting of five 
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animals All animal experiments were performed according to international guidelines and were 
approved by the local ethics committee 
Bacterial challenge 
Several bacterial strains were used to induce a middle ear response Inoculations with vital as 
well as heat-killed bacteria were performed 
Streptococcus pneumoniae 23F (SCPN23F) and Streptococcus pneumoniae 19F (SCPN\9V), 
often found in middle ear effusions, were obtained from the National Institute of Public Health 
and the Environment (RIVM, Bilthoven, the Netherlands) Stieptococcus sanguis (SCS), not 
related to otitis media, was obtained from the department of Medical Microbiology, UMC St 
Radboud, Nijmegen 
Pneumococci were routinely grown overnight on blood agar plates Before inoculation the 
bacteria were cultured at 370C overnight in 50 ml Todd-Hewitt broth and were collected after 
log phase was reached After centnfugation (160xg for 10 mm) the supernatant was discarded 
The pellet was resuspended in physiological saline (0 9 % NaCl), once more centnfuged and 
suspended again in saline The concentration of vital bacteria was determined by plating of serial 
dilutions 
Bacteria were heat-killed by incubating the bacterial suspension in a waterbath at 80oC for 
1 hour To verify the effectiveness of this procedure, 25μL· ot the bacterial suspension was plated 
on blood-agar No growth was detected after incubation at 370C for 24 hours 
Nonbacterial, antigenic challenge 
For antigenic nonbacterial challenge 37 5 μg Keyhole limpet hemocyamn (KLH, Sigma Chemical 
Company, St Louis, USA) in 25 μ ι saline was injected into the middle ear cavity according to 
the procedure of Suzuki et al " 
Nonantigenic challenge 
Active charcoal (Merck, Darmstadt, Germany) suspended in 0 9% NaCl was used for nonantigenic 
challenge The amount of active charcoal used was equal (volume/volume) to that of pelleted 
bacteria Also, physiological saline (0 9%NaCl) was used as a nonantigenic challenge and served 
as control as well because both the bacterial and nonbacterial substances were suspended in 
saline 
Experimental procedures 
Before inoculation rats were anesthetized by an intramuscular injection of 
0 05 mL/lOOg fentanyl plus fluamsone (HypnormR) (Janssen, Beerse, Belgium), and an 
intrapentonal injection of 0 1 mL/lOOg midazolam (DormicumR) (Roche, Mijdrecht, the 
Netherlands) Before otoscopy rats were anesthetized with Hypnorm1* only 
Inoculations were administered in transtympamc fashion (pars tensa) with a 30-g size 5 needle 
attached to a Hamilton microliter syringe In all procedures, rats were inoculated under otoscopie 
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surveillance Groups were as follows 
1) 25 \iL SCPN HY suspension (10s colony forming units [CFU]/mL, vital), 
2) 25 \iL SCPN 19F suspension (108 CFU/mL, vital), 
3) 25 μΐ SCPN 23F suspension (IO8 CFU/mL, heat-killed), 
4) 25 μ ι S O W 19F suspension (108 CFU/mL heat-killed), 
5) 25 μΐ SCS suspension (IO8 CFU/mL, heat-killed), 
6) 25 μL· KLH (1 5 mg/mL suspension (1 5 mg/mL), 
7) 25 μΐ* activated-coal suspension, 
8) 25 μΐ NaCI (0 9%), 
9) unchallenged control 
Otomicroscopy was performed before experimental manipulations, to assess the condition of 
the middle ear After inoculations the development of the middle ear reaction was monitored by 
means of otomicroscopy at intervals of 2 or 3 days for a total period ot 3 weeks Animals were 
killed after one, two or three weeks 
Preparation of temporal bones 
To obtain middle ear mucosae, animals were killed by aortic bleeding under anesthesia 
Subsequently, temporal bones were excised and fixed overnight at 40C in a buttered solution 
of paraformaldehyde (2% or 4%) (Merck) Thereafter, temporal bones were decalcified for 11 
days at 4 C in a Tris-hydrochlonde buffer (0 1 mol/L, pH 7 4)(Merck), ethyencdiamine tetra-
acetic acid (EDTA) (10% weight/volume) (Merck) and polyvinyl pyrrolidone (7 5%) (Serva, 
Heidelberg, Germany) Decalcified bones were rinsed in the same buffer, but without EDTA (4h, 
4 0 C ) l 6 Subsequently, the rinsed bones were snap frozen in liquid nitrogen and stored at -80ÜC 
until use Cryosections (7μπι) of the temporal bones were mounted on poly-L-lysine coated 
slides (0 1%) (Sigma-Aldnch, Zwijndrecht, the Netherlands) 
Giemsa 's staining 
To facilitate the differentiation of granulocytes, lymphocytes and erythrocytes, Giemsa's 
staining was performed on 7 μιτι cryosections Slides were soaked (30 mm) in 20 mL Giemsa-
solution (Merck, Darmstadt, Germany) diluted in 80 mL aqua dest (AD) Differentiation of the 
staining occurred in 100 mL acid AD, to which 75 μ]^ acetic acid was added Differentiation was 
completed in 96% alcohol Slides were mounted in DPX (BDH, Poole, England) 
Results 
Oiomicroscopy 
Unchallenged control ears proved to be normal at all inspections In the saline control group, 
remnants of blood in the middle ear cavity were seen and the blood vessels of the tympanic 
membrane were slightly dilated during the first days following inoculation of saline A whitish, 
thickened ring was formed in the pars tensa at some distance around the perforation (originating 
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from the injection needle) and a whitish, horseshoe-shaped discoloration of the membrane 
around the tip of the malleus. Within a few days after spontaneous closing of the perforation, the 
otomicroscopic appearance of the tympanic membrane became normal again. With regard to the 
remaining groups, each challenging substance induced an inflammatory reaction of the middle 
ear and all animals were affected. 
In all challenged ears, dilated blood vessels along the handle of the malleus and in the pars 
flaccida were seen. These remained dilated until the end of the observation period. Sometimes, 
vascularization also increased slightly. Independent of the different types of middle ear challenge 
applied in the present study, the transparent tympanic membrane became thickened, lumpy 
and opaque within a few days after challenge. The epithelium proved somewhat retracted and 
piled up, resulting in the formation of a white ring around the perforation. These membranous 
alterations diminished slowly after day 7, but at the day of sacrifice surface irregularities were 
still visible, including a horseshoe-shaped pattern around the tip of the malleus in most cases. 
In all challenged groups, a purulent or mucous effusion was observed as early as day 3 (medial to 
the pars tensa), sometimes discharging through the perforation induced by the injection needle. 
This phenomenon became less apparent during the subsequent 7 days. At the end of this period 
a transparent, serous effusion (often flocculent during the first two days) became visible in the 
superior part of the tympanic cavity (medial to the pars flaccida), which remained for 4 to 8 
days. 
In general, the variety of middle ear challenges resulted in an almost identical inflammatory 
process, with only variations in intensity. Vital bacteria often induced a more intense inflammatory 
reaction in the middle ear resulting in a more voluminous and more purulent effusion. In addition, 
the duration of the inflammatory process appeared to be somewhat elongated. 
Results are schematically depicted in Table I. 
TABLE ι. 
Middle Ear Reactions in Response to Various Stimuli. 
Challenge 
Effects 
More and dilated vessels 
Mucosal edema 
Infiltrating cells 
Seventy ol inflammation 
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+ -*- = severe/large numbere; + = pronounced, -/+ - moderate; - - / + - mlnor/amall amounts; - - absent/not applicable. 
Histology 
Histological observations in the unchallenged control group showed that granulocytes were 
almost absent in the mucosa of the tympanic cavity, and only a few lymphocytes were present. 
In the saline-group, the number of granulocytes had marginally increased. No other changes 
were observed in the mucosa (fig. 1). 
The histological findings were in line with the otoscopie observations: irrespective of the 
type of challenge (the saline-group excluded), middle ear mucosae demonstrated a similar 
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response. Characteristic features were an oedematous mucosa with a lamina propria increased 
in volume and laced with an increased number of dilated capillaries. Immunocompetent cells 
had infiltrated the mucosa in large numbers. Scattered throughout the mucosa granulocytes, 
macrophages as well as lymphocytes 
could be determined. Occasionally, 
lymphocytes were found in clusters. In the 
lamina propria, small tympanosclerotic 
plaques could be distinguished. Moreover, 
the epithelial lining had changed. Locally, 
the simple epithelium of the tympanic 
cavity transformed into areas of squamous 
epithelium. In the secretory tracts in the 
epithelium, leading to the orifice of the ET, 
activated, bulging secretory cells could be 
Fig. ι 
Normal histological appearance of the mucosal lining of the middle car 
cavity, 2 weeks after inoculation with saline. (x40) 
observed. Occasionally, epithelial polyps with clusters of infiltrating cells could be detected 
(fig.2). In fact, no differences were found 
% between the mucosae of middle ears challenged 
% _
 v
 w with cither live or dead bacteria or with KLH. 
ν The mucosae of charcoal-injected cars displayed 
a similar reaction. In addition, conspicuous 
conglomerates {in the first week) and scattered 
spots of coal were found subepithelially. Despite 
the similar appearance of the mucosae within all 
experimental groups, there was some variation 
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Fig.2 
Epithelial polyp with infiltrating cells in the mucosa of the 
tympanic cavity, 2 weeks after inoculation with live bacteria 
(S. pneumoniae I9F). (x40) 
In all cases (also when using live bacteria), the 
inflammatory response was restricted to the 
middle ear. No indications for further bacterial 




The present study indicates that any substance which is able to enter the tympanic cavity will 
induce a sterile or nonsterile inflammatory response resulting in the development of otitis media 
according to the definition of Roscnfeld and Bluestone.1 In all instances, this otitis media was 
Fig. 3 
(A) Oedematous mucosal lining of the tympanic cavity, 2 weeks after inoculation with live 
bacteria (5. pneumoniae 19F). Notice the dilated blood vessels and large numbers of infiltrating 
cells. (B) Oedematous mucosal lining of the middle ear, with dilated blood vessels and infiltrating 
cells, 2 weeks after inoculation with heat-killed bacteria {S. pneumoniae 23F). 
bv = blood vessel; 1 = lumen (A x40) (B x40) 
accompanied by effusion. The induced effects in response to the inoculation of either a bacterial 
or nonbacterial, vital or nonvital, antigenic or nonantigenic substance are similar in the first three 
weeks after challenge. Only differences in the intensity and the duration of the inflammatory 
response were observed between the various groups. 
The observation that a variety of substances can trigger the development of otitis media is 
remarkable because the middle ear has extensive protective mechanisms. Within the tympanic 
cavity, both the local (mucosal) and the systemic immune system are operative. In addition, 
mucociliary and secretory (antibacterial substances) defence systems play a role,17 as well as 
phagocytes1819 and surfactant proteins SP-A and SP-D.:o However, activation of these defence 
mechanisms does not prevent an extensive inflammatory response, as is shown in the present 
study. 
The experimental results indicate that the development of otitis media can not be attributed to a 
few bacterial species only. This is supported by several studies121421" in which a large variety of 
microorganisms has been cultured from middle ear effusions. Evidently, when applied directly 
into the middle ear, any type of microorganism or nonbacterial substance is able to trigger an 
inflammatory reaction. Consequently, in the prevention of otitis media it will be essential to 
prevent the entrance of microorganisms or other substances into the middle ear cavity. 
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The auditory bulla is an almost completely closed entity with the ET as the only connection to 
the external environment, the nasopharynx. As a result, microbes have to pass through the ET in 
order to gain access to the tympanic cavity Therefore, an important role in the pathogenesis of 
otitis media can be attributed to the ET, especially given its particular anatomy and physiology 
The posterior one-third of the ET, the osseous tympanic section, is permanently open. The 
anterior or nasopharyngeal membranocartilaginous part is closed or collapsed at rest and will 
open only temporarily during muscular action (swallow, yawn, chew) : 1 It has been suggested 
that the ET has at least three physiologic functions· equilibration of gas pressure in the middle 
ear with atmospheric pressure, protection of the middle ear from nasopharyngeal secretions, and 
clearance or drainage into the nasopharynx of secretions that are produced within the middle 
ear.' It is very likely that impairment of one or more of these functions offers an opportunity to 
nasopharyngeal microorganisms to reach the middle ear Therefore, an optimal functioning ET 
is crucial to prevent otitis media 
It remains remarkable that a selected group of bacteria and viruses (including pncumococci, 
Haemophilus influenzae and respiratory viruses) appears to be equipped particularly well to 
by-pass the defense mechanisms of the ET as may be deduced from the high prevalence of 
these microorganisms in large numbers in middle ear effusions It is even conceivable that these 
microorganisms can benefit from environmental factors in the ET. This may facilitate bacterial 
translocation into the middle car cavity and/or explosive multiplication followed by a subsequent 
mucosal response It is also possible that these microorganisms possess specific properties in 
favour of winning the microbial competition that occurs in the nasopharynx and tubal entrance : i 
Bacteria interact with each other to establish themselves and to dominate their environment 
Colonization and invasion may be facilitated or impeded by symbiosis or competition These 
interactions are mediated by several mechanisms (e.g the production of antagonistic substances, 
changes in environment and the reduction of nutrients) The most virulent strains do not always 
succeed in colonization of the nasopharynx It has been shown that an indigenous flora of 
bacterial strains of low virulence is capable of preventing the successful colonization of and 
subsequent infection by other more virulent organisms 1A:i1 It also has been demonstrated that, 
after eradication of specific pneumococcal types, nasopharyngeal recolomzation by different 
species or strains occurs 27 These successful recolomzing bacteria may contain specific genes 
(or display enhanced expression of a group of genes) that confer a selective advantage in the 
host-pathogen interaction, facilitating colonization or invasion, or both 2!! These observations 
may bear implications for the development of therapeutic strategies to protect against otitis 
media, ie, they may question the effectiveness of vaccines The studies of Lipsitch et al (2000)29 
and Pelton (2001)30 deal with this problem Those authors concluded that the success of a 
pneumococcal vaccine in reducing disease depends in part on the way in which pneumococcal 
populations change and serotype replacement occurs Nonvaccine serotypes are already present 
in the community as evidenced by the etiology of acute purulent OM This means that even if 
vaccination is successful in the eradication of the respective vaccine types of bacteria, other 
types or strains will recolonize the nasopharynx, which again may lead to otitis media This 
implies that, in the long term, vaccines may not be able to prevent the development of otitis 
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media Even if all types of bacteria could effectively be prohibited from entering the middle ear 
cavity, nonbacterial substances still may enter the middle ear and cause otitis media Therefore, 
additional therapeutic strategies, which are aimed at preventing microorganisms from entering 
the middle ear cavity, should be developed 
Conclusion 
The present study demonstrates that any substance which reaches the middle ear cavity is likely 
to induce otitis media and emphasizes the role of the ET in the pathogenesis of this disorder 
Therefore, detection of specific aspects of the ET involved in protection or in facilitating bacterial 
as well as nonbacterial translocation is of importance for the understanding of the pathogenesis 
of otitis media and the development of new therapeutic strategies Equally important is the 
elucidation of bacterial factors involved in the process of colonization and translocation 
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Abstract 
Hypothesis and Background: The eustachian tube (ET) has three important functions with 
respect to the middle ear: ventilation, clearance and protection. Surfactants are assumed to be 
important to maintain these functions. Administration of exogenous surfactant may therefore be 
effective to improve the ET function. This randomized, double blind, placebo-controlled study 
was designed to investigate the effect of exogenous surfactant on the ET function in rats. 
Material and Methods: Exogenous surfactant was administered into the middle ear of 10 
otologically healthy rats, while 10 other rats received placebo. The effect on the opening and 
closing pressure (passive ventilatory function) and the dye clearance time (clearance function) 
of the rat's ET was measured. 
Results: A significant decrease in the opening pressure was found after the administration of 
surfactant. Both surfactant and placebo caused an increase in the closing pressure. A serious 
disturbance of the dye clearance time was induced in 13 rats and the test failed in one rat. In the 
remaining 6 rats no significant difference in the dye clearance time could be found between the 
two groups. 
Conclusions: Exogenous surfactant decreases the closing forces of the ET even in otologically 
healthy rats. No significant effect on the mucociliary clearance was found, but this may be due to 
the small number of rats. Additional randomized, double blind, placebo-controlled trials, should 
be conducted to determine the clinical relevance of these changes and to further assess the effect 
of surfactant on the ET function. 
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Introduction 
The rat is a very suitable model for detailed anatomical and pathophysiological studies of the 
middle ear and the eustachian tube (ET).1"1 The morphology, anatomy and physiology of the rat's 
middle ear and ET do not differ fundamentally from that of humans. As in man, the rat's ET is 
important for ventilation, protection and clearance of the middle ear. These functions are closely 
related and render the ET into a complex structure that plays an important role in the physiology 
and pathophysiology of the middle car. 
Regulation of the middle ear pressure depends on several factors. The ventilatory function of the 
ET and the diffusion of gasses into and out of the middle car arc assumed to be the most important, 
but middle ear pressure is also affected by the production and elimination of secretions in the 
middle ear. Intermittent ventilation of the middle ear is established by contraction of the tubal 
muscles, causing active opening of the ET and allowing ventilation of the middle ear cavity.' 
Frequent opening of the ET is necessary, since gasses are constantly absorbed from the middle 
ear cavity.* Without opening of the ET, a negative middle ear pressure will develop.'' 
Clearance of secretions from the middle ear into the nasopharynx is established by the 
mucociliary epithelium and the pumping activity of the ET. The mucociliary epithelium lines the 
ventral part of the ET and is continuous with tracts of ciliated epithelium in the middle ear.7 It 
is composed of secretory cells, ciliated cells and basal cells. Mucus, released from the secretory 
cells, forms a "micron"-thick mucus blanket that covers the epithelium. Carrying dead cells, 
cell-debris and foreign particles such as dust and bacteria this mucus blanket is transported by 
the synchronized ciliary movements towards the nasopharyngeal end of the ET.17 Both cilia and 
mucus are essential for normal mucociliary transport. Any disturbance of either the cilia or the 
mucus may immediately affect normal mucociliary clearance.*9 In addition, secretions arc also 
expelled from the middle ear by the pumping action of the ET.1 0" During active opening of the 
ET by contraction of the tubal muscles, excess secretions are sucked into the posterolateral part 
of the ET. Relaxation of the tubal muscles and subsequent closure of the ET result in propulsion 
of assembled fluid towards the nasopharyngeal end of the ET. Repeated opening and closure of 
the ET finally clear the secretions into the nasopharynx. This muscular clearance is of particular 
importance when the secretion's volume is large.12 
Surfactants, produced by the ET epithelium, are assumed to be important to maintain normal ET 
function. A relative deficiency or an altered production of ET surfactant may cause a disturbance 
of the ET functions.11 Exogenous surfactant was found to reduce the pressure required to open the 
g-j- Kis However, both studies were not designed double blind, placebo-controlled nor did they 
study the effect on the closing pressure of the ET. Moreover, it is conceivable that administration 
of exogenous surfactant improves the clearance function of the ET as well, because a significant 
increase in mucociliary transport was found after the application of surfactant, both in vitro and 
in v/vo.1617 The aim of this study was to investigate the effect of exogenous surfactant on the 
opening and closing pressure as well as the mucociliary clearance function of the rat's ET in a 




Twenty otologically healthy Wistar rats, weighing 300 to 550 grams, were used in this study. All 
rats were anesthetized by intraperitoneal administration of 0.1 mL DormicumR /100 g (Janssen 
Pharmaceutica, Beerse, Belgium) and an intramuscular injection of 0.05 mL HypnormR /100 g 
(Roche, Mijdrecht, the Netherlands). They were placed in the left lateral recumbent position. 
Two incisions were made in the right tympanic membrane. One incision was used to inject 
the surfactant or placebo and the dye that was used for the clearance test. The other incision 
served as a vent. Preceding the injection, the baseline opening pressure (Po) and closing pressure 
(Pc) were measured and the difference between the Po and Pc was calculated. Subsequently, 40 
microliters surfactant or placebo were injected into the middle ear. The surfactant was derived from 
bovine lungs (surfactant-TA), supplemented with three synthetic phospholipids, and contained 
phospholipids at a total concentration of 25 mg/ml. This concentration is clinically used to lower 
alveolar surface tension in neonates. Normal saline was used as placebo. At random, ten rats 
received surfactant and ten rats received placebo. The Po and Pc were measured again 1 as well 
as 10 minutes after administration. After the final Po/Pc measurement, the rats were killed by 
exsanguination and the dye clearance time (DCT) was measured. 
Forced response test: Po and Pc measurement 
The external ear canal was sealed airtight with the probe of a TYMP87 electro-acoustic impedance 
bridge (Rexton Danplcx A/S, Copenhagen, Denmark). Before taking the measurements, a test 
was performed to verify that there was no leakage. Subsequently, the Po and Pc were measured 
six consecutive times. The Po was assessed by increasing the pressure in the middle ear, until 
the ET tube opened spontaneously. This passive opening of the ET was indicated by a sudden 
decrease in the pressure. The maximum pressure was recorded as the Po. Immediately after 
opening of the ET, the pump was turned off and the ET tube closed spontaneously. The Pc was 
the residual pressure after passive closure of the ET. 
Clearance test: DCT measurement 
Immediately after the last measurement of the Po and Pc, the rats were sacrificed. Their lower 
jaw was removed carefully and the soft palate was incised on the left lateral side to visualize 
the nasopharyngeal orifice of the ET. Subsequently, 15 microliters Evans blue solution, at a 
concentration of 20 mg/mL, were injected into the middle ear. The rat was returned to the supine 
position and the nasopharyngeal orifice of the ET was again visualized under the operating 
microscope. The time between injection of the dye and the first appearance of the dye at the 
nasopharyngeal orifice of the ET was recorded as the dye clearance time (DCT). 
Statistical analysis 
In a pilot study, the Po was increased immediately after the administration of normal saline 
into the middle ear (unpublished data). After < 3 passive openings, the fluid could no longer be 
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visualized otoscopically in the tympanic cavity and the Po returned to normal in all animals. 
Apparently, the ET must be opened a few times to perfuse the solution through the ET. Therefore 
the results of the first three measurements of Po and Pc were omitted. The means of the fourth, 
fifth and sixth Po and Pc were computed and used for the analyses in this study. 
The Po, Pc and DCT were assumed to be normally distributed variables and analyzed for means 
and standard errors of the mean (SEM). When both treatment groups were compared, means were 
analyzed with the Student's t-test. When values before and after application of the surfactant or 
placebo were compared, the paired t-test was used. 
All data were analyzed using the statistical package SPSS. 
Results 
The forced response test was performed successfully in all rats, while the dye clearance test 
failed in one rat due to technical problems. At baseline, no differences in weight and sex were 
found between the two groups. 
Forced response test 
Before the administration of surfactant or placebo, the Po as well as the Pc showed a wide 
variation between the rats. Some rats displayed low Po and Pc (minimum 137 daPa and 25 daPa, 
respectively), while others were found to have high Po and Pc (maximum 330 daPa and 142 




















Mean opening and closing pressures 
(± 2 SEM) of the surfaclanl and 
the placebo group before (solid 
square), immediately alter (solid 
circle) and ten minutes after (solid 
diamond) administration (n=20) 
Figure 1 shows the 
mean Po and Pc (± 2 
SEM) before and after 
the administration of 
surfactant and placebo. At 
baseline, no substantial 
differences in Po and Pc 
were found between the two groups. Immediately after administration of the surfactant, the Po 
decreased significantly with 24 daPa (95% confidence interval [CI] 8-41 daPa), from 215 daPa to 
191 daPa. This effect was still measured after 10 minutes. The effect of the surfactant on the Po was 
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coefficient -0.75, p=0.01).Inother words, thebiggerthedifference between the PoandPc was before 
administration of the surfactant, the larger was the decrease of the Po. Placebo had no effect on the Po. 
In both groups a significant increase in Pc was found immediately after administration as shown 
in Fig 1. In the surfactant group, the Pc increased from 80 daPa to 115 daPa (difference 35 daPa, 
95% CI 23-46 daPa), and in the placebo group, the Pc increased from 70 daPa to 116 daPa 
(difference 46 daPa, 95% CI 15-78 daPa). After ten minutes, the Pc was still significantly higher 
than the Pc before administration, but significantly lower than immediately after administration. 
No differences were found between the two groups. 
Clearance test 
In 6 of the 19 rats, the dye appeared at the nasopharyngeal orifice within 80 seconds. Three of 
these 6 rats received surfactant and had a mean DCT of 62 seconds (SEM 7 seconds). The other 
three received placebo and had a mean DCT of 75 seconds (SEM 5 seconds). This difference was 
not statistically significant (p = 0.2). 
In the remaining 13 rats, it took at least 20 minutes before the dye became visible. In these 
rats the DCT ranged from 20-43 minutes. The difference in mean DCT between the six rats, 
that received surfactant (mean DCT 22.9 min, SEM 2.6 min.) and the seven rats, that received 
placebo (mean DCT 28.1 min, SEM 3.2 min.) was not statistically significant (p = 0.2). Based 
on the observed, vast difference in DCT, the rats were considered to represent two subgroups. 
The rats with a DCT < 80 seconds were referred to as subgroup 1, while the rats with a DCT > 
20 minutes constituted subgroup 2. 
The rats in subgroup 1 were comparable to the rats in subgroup 2 with regard to weight and sex. 
However, the baseline Po and Pc were significantly higher in subgroup 2 than in subgroup 1. The 
difference in mean Po was 68 daPa (95% CI 30 - 106 daPa) and the difference in mean Pc was 
38daPa(95%CI 15-61 daPa). 
Discussion 
ET surfactant is composed of a mixture of predominantly phospholipids, especially 
phosphatidylcholines and sphingomyelins.1811' Phospholipids are known to reduce the surface 
tension at an air-aqueous interface. However, since the ET is normally closed, the ET surfactant, 
that covers the epithelium, is supposed to act as a release agent by preventing solid-to-solid 
adhesion.18 
Although the forced response test does not directly measure the physiological ability to actively 
open the ET, the test does provide useful information about the ET mechanics.2" - The Po is 
assumed to reflect the pressure which is needed to overcome all closing forces, including the 
solid-to-solid adhesion of the ET walls (luminal forces) and the pressure of the cartilage and 
other surrounding tissues (extraluminal forces). The Pc is believed to reflect the cxtraluminal 
forces, while the difference between the Po and Pc is thought to reflect the luminal forces. 
In this study, administration of exogenous surfactant was found to reduce the Po. This effect 
was correlated with the baseline difference between the Po and the Pc. Rats with higher luminal 
64 
riïcci oic\OL'cm>ii·· suillictant on 1 1 /Ίι/ιιΊιοη> 
forces at baseline showed a larger decrease in Po after the administration of surfactant, while 
all rats received the same amount and concentration of surfactant. Possibly, the concentration 
and/or composition of endogenous surfactant in the ET differs between these rats that were 
all otologically healthy, resulting in variation in luminal forces. This variation may moderate 
the effect of exogenous surfactant. However, before any final conclusions can be drawn, the 
properties of endogenous surfactant should be further revealed. Unfortunately, the clinical 
relevance of the decrease in Po remains unclear. 
The Pc increased after administration of both surfactant and placebo. This increase in Pc may 
be caused by residual fluid in the ET. Immediately after passive opening of the ET, the pressure 
pump was turned off. Subsequently, the ET closed passively. However, residual fluid in the ET, 
may have obstructed the ET lumen just before actual closure of the ET, resulting in a higher 
Pc. This effect was diminished ten minutes later, probably because the residual fluid had been 
gradually cleared from the ET. 
Clearance of the middle ear is established by the mucociliary transport and the pumping activity 
of the ET. By killing the animals, the pumping activity stops. However, the ciliary activity 
generally continues normally for several hours or even days after dcath 2 '^ Therefore, mucociliary 
transport can be measured immediately after exsanguination of the rats. In the studied population, 
contrasting results were found for the clearance test. In subgroup 1, the dye was visualized at the 
nasopharyngeal orifice within 80 seconds after injection into the tympanic cavity, while it took at 
least 20 minutes before the dye had passed the ET in subgroup 2. In other studies, mean DCTs of 
approximately 60 seconds were found in healthy rats and guinea pigs.2'1 :t< Therefore, we assume 
that for some reason a serious disturbance of the DCT was induced in subgroup 2. 
In subgroup 1, no difference in DCT was found between surfactant and placebo. Others found 
that exogenous surfactant had a positive effect on mucociliary transport rate and ciliary beat 
frequency of frog palate and dog trachea.16 '7 Allegra et al. studied frog palates (in vitro) sprayed 
with surfactant and found an increase in mucociliary transport rate of 16%.16 De Sanctis et al. 
reported a fivefold increase in tracheal mucus velocity and a twofold increase in ciliary beat 
frequency in dogs treated with surfactant.17 These effects were ascribed to the anti-adhesive 
effects of surfactant. A reduction of the adhesion between the cilia and the mucus blanket, 
may improve the effectiveness of this biological conveyor belt. The small number of rats in 
subgroup 1 may have been causative for the lack of a comparable effect in this study. 
About the cause of the delay of the DCT in subgroup 2 can only be speculated. The baseline Po 
and Pc were significantly higher in subgroup 2 than in subgroup 1. This indicates that higher 
pressures were needed to open the ET and perfuse the solution, either surfactant or placebo, 
through the ET in these animals. The mucus blanket covering the ET epithelium is known to be a 
kcyfactor in effective clearance and even small changes of this blanket may cause a disturbance 
of the mucociliary transport. :''-,n Forcing a solution through the ET may have caused such changes 
to the mucus blanket, resulting in a delay of the DCT. Possibly, rats with a high initial Po and Pc, 
i.e. with poor patency, are more susceptible to this kind of damage to the mucociliary system. 
In conclusion, exogenous surfactant was found to decrease the closing forces of the ET even 
though all rats were otologically healthy. No significant effect on the mucociliary clearance 
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was found, but this may be due to the small number of rats. Additional randomized, double 
blind, placebo-controlled trials, should be conducted to determine the clinical relevance of these 
changes and to further assess the effect of surfactant on the ET function 
References 
1 Mulder JJS, Kuijpers W Rat eustachian lube and Us musculature Ann Otol Rhinol Laryngol 1999 108 277-285 
2 Mulder JJS Morphological and functional aspects of the Eustachian tube of the rat [dissertation] Nijmegen Catholic 
University Nijmegen, 1999 
3 Albiin Ν, Ilellstrom S Slenfors LE, et al Middle ear mucosa in rats and humans Ann Otol Rhinol Laryngol Suppl 1986, 
126 2-15 
4 Albnn N, Hellslrom S, Slenfors LE Clearance ot effusion material trom the attic space an expenmcnlal study in the ral Ini 
J Pedialr Olorhmolaryngol 1983, 5 1-10 
5 Sade J, Ar A Middle car and auditory tube middle car clearance gas exchange and pressure regulation Otolaryngol Head 
Neck Surg 997,116 499-524 
6 Casselbrant ML Canlekin EI, Dirkmaal DC el al Experimental paralysis of tensor veli palatini muscle Acta Otolaryngol 
1988, 106 178-185 
7 Mulder JJ, Kuijpers W The mucosal lining of the eustachian tube ot the rat Acta Otolaryngol 1991 III 342-348 
8 Ohashi Y, Nakai Y Current concepts of mucociliary dysfunction in otilis media with effusion Acta Otolaryngol Suppl 
1991,486 149-161 
9 IIoutmeyersE Gosselink R Gayan RG el al Effects ot drugs on mucus clearance EurRcspirJ 1999,14 452-467 
10 Honjo I Ushiro K, Oka7aki N, et al Evaluation ofeusUthian tube funclion by contrast roentgenography Arch Otolaryngol 
1981 107 350-352 
11 Honjo 1, Okazaki N, Kumazawa Τ Experimental study of the eustachian tube function with regard to its related muscles 
Acta Otolaryngol 1979,87 84 89 
12 Honjo 1 Hayashi M, Ito S, et al Pumping and clearance function of the eustachian lube Am J Otolaryngol 1985 6 241-
244 
13 Miura M, Takahashi H, Sugimaru T, et al Influence of surface condition of mucosa of eustachian lube on tubal compliance 
Acta Otolaryngol 1996,116 840-844 
14 White P, Hermansson A, Svmhufvud M Surfaclant and isoprenaline effect on eustachian tube opening in rats with acute 
otitis media Am J Otolaryngol 1990,11 389-392 
15 While Ρ Effecl of exogenous surfactant on eustachian tube function in the rat Am J Otolaryngol 1989 10 301-304 
16 Allegra L Bossi R, Braga Ρ Influence of surfactant on mucociliary transport Eur J Rcspir Dis Suppl 1985,142 71-76 
17 De Sanctis GT Tomkicwic? RP, Rubin BK ctal Exogenous surfaclanl enhances mucociliary clearance in the anaesthetized 
dog EurRespirJ 1994 7 1616-1621 
18 Hills BA Analysis of eustachian surfactant and Us function as a release agent Arch Otolaryngol 1984 110 3-9 
19 Mira E, Benazzo M Tacconi MT, et al Disaturatcd phosphatidylcholine m rabbil Eustachian lube surfactant ORL J 
Otorhinolaryngol Relat Spec 1990,52 174-179 
20 Cantckm El Sac? CA, Bluestone CD, et al Airflow through Ihe eustachian tube Ann Otol Rhinol Laryngol 1979,88 603-
612 
21 Bylandcr A, Tjemslrom O Ivarsson A Pressure opening and closing functions of the eustachian tube in children and adults 
with normal ears Acta Otolaryngol 1983,95 55-62 
22 Van Meerbeek Ν Ingcls KJ, Smk AF et al Reliability of manomctric eustachian lube funclion lesls in children Otol 
Ncurotol 2001 22 183-187 
23 Ingels KJ Kortmann MJ, Nijziel MR, el al Factors influencing ciliary beat measurements Rhinology 1991 29 17-26 
24 Lee RM, Rossman CM, O'Brodovich H Assessment of postmortem respiratory ciliary inolilily and ultraslructure Am Rev 
RespirDis 1987, 136 445-447 
25 SadeJ Ciliary activity and middle car clearance Arch Otolaryngol 1967 86 128-135 
26 Downs BW, Butehom HF, Prazma J, et al Action of histamine on eustachian tube function Otolaryngol Head Neck Surg 
2001 124 414-420 
27 Sugiura Y, Ohashi Y, Nakai Y Roxythromycin slimulales the mucociliary activity of the Eustachian tube and modulates 
neutrophil activity in the healthy guinea pig Acta Otolaryngol Suppl 1997 531 34-38 
28 RheeCK JcongPS, Kim YII el al Effecl ofplalelel aclnating faclor and its antagonist on the mucociliary clearance of the 
eustachian lube in guinea pigs Ann Otol Rhinol Laryngol 1999 108 453-458 
29 King M, Gilboa A Meyer FA, el al On ihe transport ot mucus and us rhéologie simulants in cihalcd systems Am Rev 
RespirDis 1974 110 740-745 
30 EliezerN, Sade J Silbcrbcrg A, et al The role ot mucus in transport by cilia Am Rev Respir Dis 1970 102 48-52 
66 





Involvement of glycosaminoglycans in the attachment 
of pneumococci to nasopharyngeal epithelial cells 
Edith LGM Tonnaer, Theo G Hafmans, Toinc H van Kuppevelt 
Elisabeth AM Sanders, Paul E Verweij, Jo HAJ Curfs 
Microbes Infect, accepted in 2005 
C 'hapicr 6 
Abstract 
Streptococcus pneumoniae is a major bacterial pathogen involved in the development of otitis 
media. The pathogenic mechanisms of this middle ear disease, including the bacterial adherence 
mechanisms to the mucosal epithelial cells of the host, are poorly understood. In this study 
the role ofglycosaminoglycans (GAGs) in the adhesion of pneumococci to mucosal epithelial 
cells is examined. Both nasoharyngeal epithelium from rats and an oral epithelial cell line were 
used for pneumococcal adherence experiments. Preincubation of pneumococci with heparin, 
heparan sulfate and to a lesser extent chondroitin 4-sulfatc was found to inhibit attachment of 
Streptococcus pneumoniae to oral epithelial cells, while dermatan sulfate and hyaluronate did 
not interfere with pneumococcal binding. Enzymatic removal of heparan sulfate moieties by 
heparinase III from nasopharyngeal epithelial cells abolished the attachment of pneumococci to 
nasopharyngeal epithelium. 
This study demonstrates that heparin, heparan sulfate and chondroitin 4-sulfate are involved 
in pneumococcal binding to mucosal epithelial cells. This knowledge may contribute to the 
development of a new prophylactic strategy for otitis media. 
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Introduction 
Streptococcus pneumoniae (S pneumoniae) is involved in a variety of infections worldwide, 
ranging from invasive diseases with considerable mortality to relatively benign but very 
common mucosal infections, such as acute otitis media Otitis media is the most common reason 
for prescription of antibiotics in the USA. Rapidly emerging resistance to penicillin and other 
generally used antibiotics has made the development of novel therapeutic strategies for otitis 
media a high priority 
Otitis media is an inflammation of the middle ear cavity. The middle ear is an almost closed 
cavity, which can only be reached from the outside via the eustachian tube originating from 
the nasopharynx Starting from the consensus that the nasopharyngeal pneumococcal reservoir 
is the source from which pneumococci enter the eustachian tube and subsequently the middle 
ear cavity, one strategy in the prevention of otitis media may be the inhibition or eradication 
of pneumococci colonizing the nasopharynx ' 2 The process of colonization implicates several 
important aspects. Amongst these the initial and most crucial event is the bacterial adherence 
to the host cell1 Many pathogens have evolved an array of surface structures to interact with 
host cells which enables them to utilize diverse receptors Identification of host cell receptors 
exploited by microorganisms may provide the basis for the development of novel therapeutic or 
preventive strategies. 
In addition to glycolipids and other glycoproteins, bacteria as well as viruses and protozoa often 
utilize cell surface proteoglycans as receptors for adherence4 6 Proteoglycans consist of a core 
protein and one or more covalently attached glycosaminoglycan (GAG) chains GAGs are linear 
polysaccharides that are comprised of alternating disaccharide building blocks of an amino sugar 
and an uromc acid Mammalian GAGs of physiological significance are heparin, heparan sulfate 
(HS), chondroitin sulfate (CS), dermatan sulfate (DS) and hyaluronate 7 They are found on cell 
membranes, intracellular vesicles as well as in the extracellular matrix Especially HS with its 
wide distribution and accessibility on the surface of epithelial cell membranes has shown to be 
an ideal target for attachment for various microorganisms, including Listeria monocytogenes s 
Chlamydia pneumoniae,9 Neisseria sp l 0 and adenovirus " In addition, DS'2 and/or CS* are used 
for microbial adherence In this process GAGs have to be considered rather as coreccptors than 
as receptors facilitating encounters between microbial ligands and host cell surface receptors n 
In concert, a firm microbial-host attachment is achieved Whether this applies for pneumococci 
too is unknown, therefore a study was designed to investigate this Because, when GAGs indeed 
prove to play a role in pneumococcal adherence to host cells this knowledge may be used to 
enable the development of anti-adhesive agents to prevent pneumococcal colonization and 
consequently otitis media 
The present study was performed to determine whether HS and / or other GAGs are involved in the 
adherence of Streptococcus pneumoniae to nasopharyngeal epithelial cells. Both nasopharyngeal 
epithelium from rats and an oral epithelial cell line were used for adherence experiments with 
pneumococci. 
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Materials and methods 
Animals and experimental conditions 
5 Female specific pathogen-frcc rats, Lewis strain (Charles River, Someren, the Netherlands), 
4 weeks of age, were used Animal experiments were performed according to international 
guidelines and were approved by the local committee on animal ethics 
Bacterial culture 
For all adherence assays Streptococcus pneumoniae 19F (SCPN19F) (RIVM, Bilthoven, The 
Netherlands) was used routinely grown overnight on blood agar plates Before adherence, 
bacteria were cultured at 370C overnight in 50 ml Todd-Hewitt broth and were collected after log 
phase was reached After centnfugation (160xg for 10 mm), the supernatant was discarded The 
pellet was resuspended in saline (0 9% NaCl), centnfuged once more and suspended in DMEM 
The concentration of viable bacteria was determined by plating of serial dilutions 
Pneumococcal adherence in vivo 
Pneumococcal attachment to nasopharyngeal epithelial cells (in the proximity of the entrance of 
the Eustachian tube) was initiated by injection of a pneumococcal suspension into both cars of a 
Lewis rat via the tympanic membrane, as described before l 4 Briefly per ear 30 μΐ of a suspension 
of live pneumococci (10s CFU/ml) was inoculated through the tympanic membrane into the 
middle ear cavity of anaesthetised rats (0 05 mL/100 g fentanyl plus fluamsone [HypnormR, 
Janssen, Beerse, Belgium] ι m and 0 1 mL/100 g midazolam [Dormicum11, Roche, Mijdrecht, 
The Netherlands] ι ρ ) The inoculated pneumococci were automatically transported (mucociliary 
transport) via the Eustachian tube (ET) into the nasopharynx Four hours after pneumococcal 
inoculation rats were sacrificed by a CO, overdose It has been shown that transtympamcally 
inoculated solutions in rats reach the nasopharynx within 15 mm " 
Cupromeronic blue staining 
Cupromeronic Blue (CB) is a catiomc dye, developed specifically for electron microscopic 
localization and characterization of proteoglycans and sulfated GAGs Freshly prepared epithelial 
tissue blocks from the nasopharynx of inoculated Lewis rats and one control rat were processed 
according to Pieper et al "' Epithelial specimens were immersed for at least 16 hours in 0 025 M 
sodium acetate buffer (pH6 5) containing 2 5% glutaraldehydc (Merck, Darmstadt, Germany), 
0 2%(CB) (Seikagaku Co , Tokyo, Japan) and 0 2 M MgCl^Sigma-Aldnch, Zwijndrecht, The 
Netherlands) Specimens were washed ( 3 x 1 0 mm) in staining solution without CB, washed in 
distilled water containing 1% sodium tungstatc (Sigma-Aldnch, Zwijndrecht, The Netherlands) 
(3 χ 10 mm) and dehydrated through ascending concentrations of ethanol (up to 70% ethanol 
containing 1% sodium tungstatc) and ethanol-propyleneoxide mixtures, and finally embedded in 
Epon 812 (Serva, Heidelberg, Germany) Ultrathin sections (with and without saturated uranyl) 
acetate were examined with a Jeol 1010 electron microscope 
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Specificity of pneumococcal binding to mucosal tissue blocks 
To verify whether the specificity of pneumococcal binding to nasopharyngeal epithelial cell 
membranes was associated with specific GAGs, enzyme digestions were performed before 
bacterial adherence. Small nasopharyngeal, mucosal tissue blocks (control rat) were incubated 
for 2 hrs on a rocker platform at 370C with hepannase III (hepantinase, from Flavobcittenum 
hepanmim, a kind gift from IBEX Technologies Ine , Montreal, Quebec, Canada, digests HS 
exclusively), 0 04 lU/ml in 50 mM NaAc, 50 mM CaiAc), buffer, pH 7 0 and rinsed 5 x 5 mm 
in saline Subsequently, each tissue block was soaked in 0 5 ml of a pneumococcal suspension 
(IO* CFU/ml), briefly ccntrifuged (impulse centnfugation, HOxg) and incubated on a rocker 
platform, for 30 mm at at 37"C Finally, unattached bacteria were removed by 2 washings with 
saline Tissue blocks were further processed for CB staining (see above). Ultrathin sections (with 
and without saturated uranylacetate) were examined with a Jeol 1010 electron microscope 
Localization of cell surface HS-epitopes 
To verify whether HS-epitopes could be identified on nasopharyngeal epithelial cell surfaces 
small mucosal tissue blocks (control rat) were prepared for immunoelectron microscopy 
(immuno-EM) Tissue blocks were immediately frozen in liquid propane (-190ÜC) using a rapid-
freeze apparatus (KF80, Reichert-Jung) and embedded at low temperature More in detail, tissue 
was freeze-substituted by methanol containing 0 5% uranylacetate at -900C in a CS auto freeze 
susbstitution apparatus [Reichert-Jung]) and embedded at -450C in Lowicryl HM20 resin (Bio-
Rad Laboraties, Ine ) l7 
A postembedding immunohistochcmical technique17 was applied on ultrathin sections For 
identification of HS epitopes a phage display-derived antibody (EW4D2), that reacts with 
both heparin and HSIS was used, subsequently a second antibody (P5D4, recognizing the C-
termmal vesicular stomatitis virus glycoprotein VSV-G) was applied which was labeled with 
a 10 nm goldmarkcr (gold labelled goat anti-mouse IgG+IgM [H+L])(Aunon, Wagemngcn, 
Netherlands) Ultrathin sections (without uranylacetate) were examined with a Jeol 1010 electron 
microscope 
Pneumococcal binding to cultured epithelial cells (SCC-15) 
To study pneumococcal binding to epithelial cells an oral epithelial cell line SCC-15 was used 
(a kind gift of J G Rhcinwald, Harvard Medical School, Boston, Massachusetts) SCC-15 cells 
were cultured according to method previously described by Rheinwald et all9 Before the binding 
experiment, feeder cells were removed by sequential trypsmization and SCC-15 cells were seeded 
on Thermanox cover slips in a 24 wells plate. At subconfluence, 24h before administration of 
pneumococci, medium was exchanged for the same medium without antibiotics Subsequently, 
cell layers were rinsed with fresh DMEM without additives (3χ), and medium was removed 
Thereafter, 250 μ ι GAG-treated (see below) or untreated, live pneumococci (IO8 CFU/ml) were 
added per well Plates were ccntrifuged at 160xg for 5 min in a plate spinner" and subsequently 
incubated at room temperature for 30 min on a rocker platform to facilitate contact between 
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bacteria and epithelial cells Thereafter, plates were rinsed (4x) with saline to remove unbound 
bacteria Finally, wells were filled with methanol (100%) for fixation Covershps were Giemsa 
stained and analysed by light microscopy 
Specificity of pneumococcal binding to cultured epithelial cells 
In addition to the control binding experiments described above, specificity of pneumococcal 
binding was tested by preincubating pneumococci in different GAG suspensions prior to the 
adherence assay with SCC-15 cells Pneumococcal preincubations were performed with Heparin 
(a structural analogue of HS) from porcine intestinal mucosa, HS from porcine intestinal mucosa, 
chondroitin 4-sulfate (C-4S) from whale cartilage, chondroitin 6-sulfate (C-6S) from shark 
cartilage, dermatan sulfate (DS) from porcine intestinal mucosa and hyaluronate from human 
umbilical cord (all from Sigma, St Louis, MO) Pneumococci were incubated with 20 μg GAG/ 
ml in saline for 1 hr at 370C on a rocker platform and were used directly for binding assays 
To assess whether pneumococcal adhcsins involved in epithelial binding are protcinaceous, 
pneumococcal adherence to cultured oral epithelial cells was assayed after preincubating 
pneumococci in a trypsin solution (0 05% trypsin in PBS, 30 mm, 37° C) and washed 5χ in 
saline before starting the binding assay 
Quantification of 5. pneumoniae adhesion 
Digital images were taken randomly from 3 locations per slide or coverslip The mean number 
of adhered bacteria per 100 cells was calculated, by counting the number of all adhered bacteria 
in one image This number was devidcd by the total number of cells present in the same 
image Subsequently, the results of 3 locations were converted to the mean number of adhered 
pneumococci per 100 cells 
Results 
Cupromeronic blue staining 
Detection of adherent pneumococci in tissue samples from inoculated rats showed bacteria 
scattered (in small groups) throughout the nasopharyngeal epithelium After cupromeronic blue 
staining, GAGs were detectable as characteristic, filamentous or bristle shaped structures of 
varying length, present on luminal cell membranes of squamous epithelial cells, on microvilli 
(fig 1A) as well as on cilia of respiratory cells In addition, GAG structures were observed 
in pneumococcal capsules (particularly in voluminous capsules) reflecting the presence 
of pcptidoglycans (bacterial GAGs) in capsules of gram positive bacteria On contact sites 
between pneumococci and epithelial cells, GAG structures of both epithelial membranes and 
pneumococcal capsules appeared to be intermingled (fig IB) 
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No differences were observed between GAGs present on cell surfaces of nasopharyngeal 
epithelium in control rats or inoculated rats (data not shown). 
A 2 ^ Β • Μ 1 Mm 
Fig.l. Λ. Electron microscopic detail of a secretory nasopharyngeal epithelial cell. GAGs arc present on the microvilli as bristle 
structures of varying length (arrows). (Cupromcronic blue as well as uranylacctate staining.) B. Transmission electron micrograph 
of pneumococcal attachment to squamous nasopharyngeal epithelial cells. Intenningled GAG stnictures are indicated at one of the 
adherence sites (arrow) and shown in the insert at higher magnification. (Cupromeronic blue staining; uranylacctate omitted.) 
Specificity of pneumococcal binding 
After ezymatic treatment of fresh 
nasopharyngeal, mucosal tissue blocks of 
a control rat with heparinase III, followed 
by a pneumococcal adherence assay, no 
attached bacteria could be detected at the 
mucosal surface. Furthermore, the typical 
GAG structures at the mucosal cell 
surfaces could not be identified anymore 
by electronmicroscopy (fig.2). 
Fig.2. Electron microscopic detail of nasopharyngeal 
squamous epithelial cells after treatment with heparinase 
HI. No GAG structures are visible at the cell surface. 
(Cupromeronic blue staining, uranylacctate omitted.) 
Localization of cell surface HS-epitopes 
lmmuno-EM results showed the presence of HS-epitopes in the luminal cell membranes of the 
nasopharyngeal epithelium of the control rat (fig.3), as can be concluded from the localization 
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Fig.3. 
Electron microscopic detail of a 
nasopharyngeal squamous epithelial 
cell after incubation with HS-antibody 
(EW4D2). Ooldparticles, arranged along 
the luminal cell surface, indicate I1S-
epitopes. (Uranylacate staining omitted.) 
Specifìcty of pneumococcal binding 
The specificity of pneumococcal adherence was tested in repeated (at least 3χ) series on almost 
confluent cells of cell line SCC-15. Prior to the adherence assay pneumococci were incubated 
with different GAGs to establish the specificity of binding. As a control in each experiment, 
pneumococcal adherence to oral epithelial cells was also established in the absence of GAGs. 
Per experiment the amount of adhered pneumococci per cell in the control group was used as a 
standard to calculate the percentage of inhibition in binding after pneumococcal preincubation 
with different GAGs. The results are depicted in fig.4. (Diagram) 
5 0 0 
Fig.4. Effects of pneumococcal preincubations with specific GAGs on adherence of live pneumococci to cultured epithelial cells. 
As can be observed in fig.5A, adherent pneumococci are not evenly distributed over the cells. 
As is shown in fig.4 and illustrated in fig.5, pretreatment of 5. pneumoniae[9F with heparin and HS 
inhibited bacterial adherence to a large extent. To a lesser degree, also pneumococcal pretreatment 
with C-4S displayed some inhibitory effect on bacterial attachment, while pretreatment with 
chondroitin 6-sulfate, DS or hyaluronate (indicated as "hyaluron" in the figure) did not affect 
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pneumococcal binding to epithelial cell membranes. Furthennore, in several of these adherence 
experiments with S. pneumoniae 19F the inhibitory effect of heparin was tested in two 
concentrations (20 μg/mL and 40 μg/mL). When a higher concentration of heparin was 
applied a significant increase of inhibition of pneumococcal binding was observed, indicating a 
concentration dependent effect. 
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Fig.5. Almost confluent SCC-15 cells incubated with a suspension of Streptococcm pneumoniae 19F. A. Pneumococcal adherence 
without pretreatment. Β. Pneumococcal adherence after pretreatment with C-4S. C. Pneumococcal adherence after pretreatment with 
HS. (Giemsa staining. LM) 
In a pilot experiment comparable results were obtained when 5. pneumoniae 23F was used to 
study in a similar way the inhibitory effects of GAGs on pneumococcal adherence to epithelial 
cells. 
To identify whether pneumococcal adhesins involved in epithelial binding are proteinaceous 
pneumococci were treated with trypsin prior to the adherence assay. Since trypsin is a proteolytic 
enzyme, treatment of pneumococci with this enzyme will degrade pneumococcal surface 
proteins. Pneumococcal pretreatment with trypsin completely abolished bacterial adherence to 
oral epithelial cells in vitro (results not shown). 
Discussion 
The present study demonstrates that GAGs, especially HS and to a lesser extent C-4S, present in 
the luminal cell membranes of mucosal epithelial cells, are involved in pneumococcal binding. 
Trypsin treatment of pneumococci prior to a pneumococcal adherence assay prevented bacterial 
attachment, which is indicative of a proteinaceous adhesin as pneumococcal counterpart. 
Since specific information about the distribution of GAGs in cell surface proteoglycans from 
nasopharyngeal epithelium was not available, this was studied more in detail. The presence 
of GAGs on luminal membranes of nasopharyngeal epithelial cells was demonstrated by 
cupromeronic blue staining. Immuno-EM staining revealed that HS is one of these GAGs, shown 
by HS labeling along these luminal cell surfaces. This is in line with the GAG distribution of 
cell surface associated proteoglycans from oral epithelia that prove to contain predominantly 
HS,2 1 2 2 although also some hybrid proteoglycan structures have been detected in epithelial cell 
surfaces containing both HS and CS [23]. The presence of dermatan sulfate is less common.7 
This predominant presence of HS in epithelial cell membranes may explain why especially HS is 
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exploited as host receptor by various pathogens This holds true for pneumococci, since this study 
demonstrates that pretreatment of epithelial cells of nasopharyngeal tissue with hepannase III 
blocks pneumococcal adherence In addition, HS as well as heparin (a more sulfated analogue 
of HS) displayed the highest efficacy in inhibiting pneumococcal binding to epithelial cell 
membranes m vitro, which appears to be a concentration dependent effect Apart from HS it was 
shown that chondroitm 4-sulfate is involved in pneumococcal adherence, although to a lesser 
extent This may be ascribed to the fact that smaller quantities of CS are present in epithelial 
cell surface proteoglycans21 while from this smaller amount only C-4S seems to have a receptor 
function Furthermore, neither chondroitm 6-sulfate, DS sulfate nor hyaluronate seem to play a 
role in the attachment of pneumococci to mucosal epithelial cells as these GAGs did not display 
any inhibitory effect m vitro Adherent pneumococci are not evenly distributed over the cells 
as can be observed in fig.5A Some epithelial cells do not show any pneumococci at all This 
may reflect differences in the exposure of cell surface molecules during different developmental 
stages, including those surface molecules that are involved in pneumococcal binding 
Although it is clear that GAGs (HS and / or C-4S) mediate pneumococcal attachment, other 
molecules in the cell surfaces of mucosal epithelial cells may also contribute to pneumococcal 
binding, which is indicated by the fact that the inhibitory effect of GAGs never reached 100%. 
It is known that GAGs often act in concert with other cell surface receptors to promote hgand 
binding,24 but the precise sequence of events that occur during bacterial attachment to host cells 
has not been studied so far Rostand and Esko-1 postulated that the initial interaction of microbes 
with HS is a relatively weak one Microbial binding will become stronger as soon as non-HS 
receptors become involved This assumption implies that cell surface HS acts as a co-receptor, 
initiating interactions with an array of host receptors ultimately leading to a stronger binding due 
to a decrease in physical distance induced by the initial binding of the bacterium to HS on the cell 
membrane. It is also conceivable however, that HS-binding triggers a signaling cascade resulting 
in the expression of new receptors employed in microbial binding " 
As has been demonstrated by others, pneumococci may utilize several glycoconjugates for 
binding, e g specific carbohydrate sequences of glycolipid receptors that are present on cell 
membranes of resting pneumocytes and tracheal epithelial cells 2S 27 Furthermore, following 
bacteria-induced cytokine activation, a change in receptor expression on epithelial cells has 
been observed Not only a new carbohydrate receptor for pneumococcal adherence that is not 
available on resting cells has been identified,26 but also an increase of platelet-activating factor 
receptor (PAF-R) expression has been reported leading to an increase in amount of adherent 
pneumococci26 2l) 
All in all these observations suggest that GAGs are involved in the initial phase of pneumococcal 
binding to the host, possibly simultaneously with specific carbohydrate sequences of glycolipid 
receptors observed in former studies ^ 27This knowledge may be used to conceive and develop 
novel therapeutic interventions aimed at prevention or detachment of adherent pneumococci 
at an early stage thereby preventing the development of pneumococcal otitis media Such a 
therapeutic strategy may be found in the administration of receptor analogues as anti-adhesive 
agents, i.e a cocktail of specific carbohydrates, including GAGs for which heparin may be a 
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good candidate as has been shown in the present study. Since carbohydrates are not toxic nor 
immunogenic, such a cocktail may be considered to be a relatively mild approach. In addition, 
therapeutic benefits other than inhibition of bacterial attachment are possible. To illustrate, it 
has been shown that nebulized heparin in cystic fibrosis patients also has an anti-inflammatory 
eflfect, through reducing levels of interleukins 6 and 8 in sputum, in addition to its mucolytic 
effect.30 Theoretically, such a carbohydrate cocktail may afford protection against a spectrum of 
bacterial and viral respiratory pathogens, offering a novel prophylactic strategy 
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Chapter 7 
Abstract 
This study describes the development of a physiological rat model for otitis media. The model 
is based on the assumption that bacteria, intranasally introduced into the nasopharynx, will be 
transferred into the middle ear cavity during swallowing provided that the ambient air pressure 
is higher than the middle car pressure. This model demonstrates that small pressure changes, 
generated in a pressure cabin under controlled conditions can be used as driving force for the 
transfer of bacteria into the middle ear cavity resulting in bilateral otitis media. Because invasive 
techniques or biochemical agents are not applied this model is suited to in vestigatc immunological 
aspects of otitis media, including the effects of vaccination. 
84 
Bjctcihil otiti* tìicdhi j new iion-in\<iii\e un model 
Introduction 
Otitis media (OM), an inflammation of the middle ear cavity, has a multifaced etiology determined 
by a variety of genetic and environmental factors.' Consequently, no single animal model can be 
considered as a truly physiological model. To study the pathogenesis of OM, various methods 
have been applied to induce middle ear inflammation in mice,21 rats,45 gerbils,''7 guinea pigs,1*9 
chinchillas10" and even monkeys12" with varying degrees of success. In most animal models, 
acute OM is induced by direct inoculation of bacteria into the middle ear cavity via the tympanic 
membrane or bulla. This method is acceptable as long as the outcome of the study is supposed 
to be independent of the way in which the experimental infection is established, and therefore is 
mainly used to study the effectiveness of antibiotics. However, as soon as research focusses on 
the pathogenesis and/or the prevention of OM, animal models that closely resemble the natural 
course of OM in humans are required; this implies infection of the middle ear cavity via the 
eustachian tube. Until now, such a model has been described for chinchillas only.10 OM could be 
induced when nasal bacterial inoculations were combined with a complicated middle ear deflation 
method. By deflating the middle ear, a negative pressure promoted the entrance of bacteria into 
the tympanic cavity, which resulted in OM in 60% of the animals. Both, this moderate rate of 
induction as well as the complex procedure required, render this model less ideal. Apart from 
this, another drawback is the difference between the eustachian tube function of chinchillas 
and humans, i.e. its scmipatulous constitution.14 Various other animal models arc based on an 
experimentally induced dysfunction of the eustachian tube. Mirano et al.l'i inoculated influenza 
A virus intranasally prior to bacteria. The viral inoculations resulted in mucosal changes and 
negative middle ear pressure that promoted bacterial ascent into the tympanic cavity. Others 
induced mucosal changes in the middle ear cavity by injecting histamine through the tympanic 
membrane,4 abrogating mucociliary clearance and thus facilitating the entrance of bacteria into 
the middle ear. Schousboe et al.16 transected the tensor veli palatini muscle to prevent the opening 
of the eustachian tube, thereby impeding both ventilation and clearance of the tympanic cavity. 
However, neither these three models nor various others described elsewhere12 n are suitable to 
study immunological aspects of the pathogenesis of OM because histamine as well as other 
pro inflammatory mediators resulting from tissue trauma interfere with mucosal immunological 
processes. 
In order to study immunological mechanisms contributing to the pathogenesis of OM, we 
developed a rat model reflecting the natural course of OM more closely. Because both rats and 
mice are well-characterised animals with respect to genetic, microbiologic and immunologic 
determinants, they are often chosen as laboratory animals. Given the similarities of the middle 
ear and eustachian tube of the rat to those of humans,17'20 the development of a rat model was 
preferred. Small pressure changes were used as the driving force to facilitate the translocation 
of intranasally inoculated bacteria from the nasopharynx into the middle ear cavity during 
swallowing resulting in OM. Streptococcus pneumoniae was chosen because of the high 
incidence of these bacteria in middle ear effusions in which some seven pneumococcal 
serotypes, including S. pneumonia \9F(SCPN19F), dominate.21 
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Material and Methods 
In all experimental procedures female pathogen-free Lewis rats (Charles River, Someren, the 
Netherlands), 4 weeks of age were used. All animal experiments were performed according to 
international guidelines and were approved by the local ethics committee. 
/ Bacterial culture 
SCPN19F (RIVM, Bilthoven, the Netherlands) was routinely grown overnight on blood agar 
plates. Before inoculation, the bacteria were cultured at 370C overnight in 50 mL Todd-Hewitt 
broth and were collected after log phase was reached. After centrifugation ( 160 χ g for 10 min) the 
supernatant was discarded. Unless stated differently, the pellet was resuspended in physiological 
saline (0.9%NaCl), centrifuged once more and suspended in saline. The concentration of vital 
bacteria was determined by plating of serial dilutions. 
2 Pressure cabin 
The design for the pressure cabin was made by W. van de Wijdeven (Orthopaedic Research 
Lab, UMC St Radboud, Nijmegen). Modderkolk Projects & Maintenance Ltd. (Wychen, the 
Netherlands) manufactured a prototype of this design that was used in all experiments. The 
cabin consists of a perspex tube (length: 30 cm; diameter: 15 cm) with a fixed perspex rear wall. 
This rear section contains a manometer, an outlet valve and a valve connected to a cylinder with 
compressed air. The removable perspex front door is sealed with a rubber O-ring (Fig.l). Air 
pressure in the cabin can be increased step-by-step and monitored by the manometer. Pressure 
decrease is realised by opening of the outlet valve. 
Fig.l Protolypcof pressure cabin 
I = perspex tube. 2 = inlet valve. 3 = outlet valve. 4 = manometer. 5 = removable front door 
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3 Monitoring and evaluation 
Otomicroscopy was performed at the start of the experiments and at regular intervals (every 2 or 
3 days) after manipulation, to monitor the middle ear status after pneumococci were applied. Ten 
days after application of pneumococci, rats were sacrificed by CO, overdose. Temporal bones 
were removed and processed for histological screening. The right temporal bone was dissected 
en bloc and transferred to 4% paraformaldehyde (Sigma Chemical Co., St. Louis, MO) in 0.1 M 
phosphate buffer (pH 7.4) for 4 h at 4 "C. Fixation was followed by decalcification in EDTA 10% 
(Merck, Darmstadt, Germany), polyvinylpyrrolidone (PVP) 7.5% (Serva, Heidelberg, Germany) 
in 0.1 M phosphatebuffer (pH 7.4) at 4nC for 1 week. After extensive rinsing in phosphate buffer 
tissue blocs were dehydrated in alcohol (70, 96, 100%) and embedded in methyl mcthacrylate 
(MMA) (Merck). 
The left temporal bone was opened and the middle ear mucosa was dissected. The mucosa 
was fixed in paraformaldehyde 4% for 4 h at 40C, rinsed in 0.1 M phosphatebuffer (pH 7.4), 
dehydrated in alcohol and embedded in MMA. 
Sections (7 μηι) were cut on a Reichert-Jung 2050 cryostat, mounted on glass slides precoatcd 
with gelatin (Merck) 1.25% in aquadest and stored 24 h at 37ÜC before staining with Mayer's 
hacmalum. 
In those procedures in which Evans Blue (Merck) was used, only one otoscopie inspection (1 
day after inoculation) was performed. Thereafter, the rats were sacrificed. Nose, nasopharynx, 
eustachian tube and middle ear cavity were opened by dissection and the presence of staining 
fluid was observed microscopically. 
4 Microbiology of the middle ear effusions 
After otoscopie verification of OM, rats were killed by CO, overdose and the temporal bones 
were dissected en bloc. Thereafter, the bulla was opened at the medial side with sterile equipment. 
A small part of the middle ear effusion was removed and transferred to a blood agar plate, which 
was incubated overnight ( 37ÜC; 5% CO,). Sodiumdesoxycholate (10%) in aqua dest was added 
to grown colonies with pneumococcal morphology. Dissolution of the colonies within 0.5 - 2 h 
is indicative of pneumococci. 
5 Experimental set up 
Before inoculation rats were anesthetised by a mixture of isoflurane (0.5%) (Abbott, Hoofddorp, 
the Netherlands) and oxygen/nitrous oxide (1:1 ) in a fume hood during 7 min. The pneumococcal 
suspension was introduced into the nose through a teflon cannula, which was inserted 2 cm via 
the right nostril, unless stated differently. Immediately thereafter, the rats were transferred to a 
pressure cabin. In this cabin, atmospheric pressure can be raised and reduced gradually in small 
steps. 
To determine the optimal procedure for induction of OM, several experimental designs were 
compared. For each experiment, a small number of rats (n = 4 - 6) was used. 
In the first series of experiments, Evans blue (0.1 % in saline) was used in order to trace the path 
of the inoculated fluid and to establish whether the inoculum reaches the middle ear cavity. 
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5.1 Evans blue tests 
Two different intranasal application methods were compared: 
• Bilateral inoculation of Evans Blue (30μΕ per nostril) by means of a pipet tip 
(depth: 1 cm). 
• Bilateral inoculation of Evans Blue (30μΕ per nostril) through a thin cannula 
(depth: 2 cm). 
After inoculation, rats were transferred to the pressure cabin and pressure was increased up to 
100 kPa and immediately thereafter reduced gradually until normal atmospheric pressure. 
In addition, two tests were performed to compare differences in continuous and discontinuous 
pressure increase and decrease, as well as to assess the minimal effective pressure for the model. 
For both tests, bilateral nasal inoculations (cannula) of 30 μΕ Evans blue (0.1%) in saline were 
used. 
• Pressurisation was performed in steps of 5 kPa or 10 kPa until a final pressure of 50 kPa 
was reached. The subsequent pressure reduction was made in comparable steps. 
• Continuous pressure increase was terminated at different final pressures: 30, 40 or 50 
kPa. 
5.2 Bacterial inoculations 
The results of the Evans blue pilots were applied in experiments with SCPN 19F. To select 
the optimal method for a high and reproducible rate of bacterial OM several procedures were 
compared. 
5.2a Pressure start 
To determine the optimal moment to initiate pressure increase, two time points were evaluated 
(after bilateral inoculation of a suspension of SCPN 19F 10* CFU/mL, 30μΕ per nostril by means 
of a cannula). 
• Just after the rat regained consciousness, pressurisation was initiated in measured steps 
(step size of 5 kPa / 50 kPa max). 
• Before the rat regained consciousness, overpressure (5 kPa) was generated. Thereafter, 
pressure increase was continued in measured steps continued until 50 kPa max. 
In both methods pressure decrease was comparable. 
5.2b Unilateral versus bilateral inoculation 
To determine whether the induction rate of OM is influenced by bilateral or unilateral bacterial 
inoculations, both application methods, followed by pressure increases and decreases in the 
pressure cabin (steps of 5 kPa/ 50 kPa max), were evaluated. 
• A suspension of SCPN 19F (IO" CFU/mL, 30 μΕ each) was inoculated (cannula) into 
both nostrils. 
30 μΕ of a SC/W /^suspension (10'" CFU/mL) was inoculated (cannula) into the right 
nostril only. 
5.2c Suspension viscosity and body position 
To establish the influence of the viscosity of the inoculated suspension and the effect of the position 
of the rat in the pressure cabin on the induction of OM, two combinations were evaluated. 
• 30 μΕ of a SCPN 19F suspension (10'° CFU in ImL saline) was inoculated (cannula) 
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into the right nostril of the rat. Subsequently, the rat was placed on its left side in the 
pressure cabin in which 5 kPa overpressure was generated before awakening. 
• 30 μ ι of a SCPN19F suspension (10'" CPU in saline to which methylcellulose [1%] was 
added) was inoculated into the right nostril. The anesthetised rat was placed on its back 
in the pressure cabin in which 5 kPa overpressure was generated before awakening. 
Both combinations were followed by pressure increase in measured steps (steps: 5 kPa / 50 kPa 
max) and a comparable pressure decrease. 
6. Controls 
• Two rats were inoculated with saline to which methylcellulose (1%) was added. 
Thereafter, they were transferred to the pressure cabin in which 5 kPa overpressure was 
generated. After awakening, pressure was increased in measured steps (steps: 5 kPa / 
50 kPa max) and decreased in a comparable way. 
Two rats were inoculated (cannula) with 30 μ ι of a 5CP/V79F suspension (lO^FU/mL 
in saline) into both nostrils. Subsequent transfer to the pressure cabin was omitted. 
7 Final infection method (model) 
The right nostril of the rat was inoculated with 30 μL· of a pneumococcal suspension 
(SCPN 19F, 1010 CFU/mL, in saline containing 1% methylcellulose) by means of a cannula, 
inserted 2 cm into the right nostril. Subsequently, the rat was placed on its back in the pressure 
cabin. Before the rat regained consciousness, pressure was increased by 5 kPa. Soon after 
recuperation, the rat starts swallowing. After the rat started swallowing, pressure was increased 
with steps of 5 kPa until the final pressure of 50 kPa was reached. Thereafter, the procedure was 
executed in reverse order until atmospheric pressure was reached again. 
• As controls, three rats were inoculated with methylcellulose (1%) in saline. 
• Three infected cars were used to assess the presence of pneumococci in the middle ear 
effusion. 
Results 
Ad 5.1 Evans blue tests 
1. After bilateral nasal inoculation of Evans blue with a pipet tip and subsequent pressure 
increase up to 100 kPa, dissection revealed that staining fluid was confined to the the 
distal part of the nose. After deeper inoculation, by means of a cannula, one or both 
tympanic cavities stained blue. In all rats, blood vessels of the tympanic membrane were 
dilated extensively and some small haemorrhages were detected which indicated that the 
maximum overpressure of 100 kPa was too high. 
2. Only discontinuous pressure increase in steps of 5 kPa up to 50 kPa, after inoculation 
of Evans blue, did result in the appearance of staining fluid in the middle ear cavities 
of one or both cars. A lower total pressure increase was not sufficient. Steps of 10 kPa 
to increase pressure resulted in dilated blood vessels of the tympanic membrane, while 
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steps of 5 kPa did not affect the vasculature. 
Ad 5.2 Bacterial inoculations 
1. When pressure increase started after the rat had regained conciousness, no signs of 
middle ear inflammation could be detected (neither otoscopically nor histologically). 
However, the initiation of a presure increase after pneumococcal inoculation, while the 
rat was still anesthctised, resulted in unilateral or bilateral OM with a purulent effusion 
within 4 days. 
2. Because bilateral inoculations often resulted in respiratory problems (three rats even 
died due to suffocation) a smaller amount (30 μ ι ) of a more concentrated bacterial 
suspension (10IC CFU / mL) was inoculated unilaterally. Within 4 days, inoculation of 
the right nostril resulted in OM in the left ear when the rat was placed on its left side in 
the pressure cabin, while the right middle ear was not affected. 
3. Methylcellulose (1%) was added to the suspension to enhance viscosity to prevent the 
inoculated fluid from vanishing immediately into the oropharynx. After inoculation, the 
anesthetised rat was placed in a dorsal position (not on its side) in the pressure cabin to 
promote the draining of the bacterial suspension into the nasopharynx in close proximity 
of both eustachian tube openings. This procedure resulted in bilateral OM in all rats 
within 4 days. 
Ad 6 Controls 
• None of the rats intranasally inoculated with saline / methylcellulose developed 
OM within 10 days. 
Intranasal inoculation of the pneumococcal suspension at atmospheric pressure, 
without a subsequent pressure increase, did not result in signs of inflammation 
in the middle ear cavity within 10 days. Otoscopy revealed normal, healthy, 
transparant tympanic membranes and a normal middle ear aspect in all cases. 
Upon histological examination, no changes in the middle ear mucosa were 
observed either. 
Ad 7 Final infection method (model) 
Systematic adjustments, based on results of preceding experiments, resulted in a final technique 
that induced OM in all animals. In order to confirm that this method represents a reliable 
physiological model for OM, six additional rats were treated according to the same protocol 
and they all developed bilateral OM within 4 days, as confirmed by otoscopy. Small amounts 
of middle car effusions were collected and transferred to blood agar plates for determination 
of pneumococci. In all cases, only bacterial colonies of uniform morphology were detected. 
Additional diagnostic tests proved all these bacteria to be pneumococci. 
None of the control rats developed OM within 10 days after intranasally inoculation with 
methylcellulose (1%) in saline followed by a similar procedure in the pressure cabin. 
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In all cases in which pncumococci were used, the inflammatory response was restricted to the 
middle ear. No indications for further bacterial dissemination were observed. 
Summary of the crucial aspects in the experimental procedure to induce 
bilateral pneumococcal otitis media in the rat 
• Deep intranasal inoculation 
• Characteristics of the unilateral pneumococcal inoculum: 
Small volume (30 μ ι ) 
Concentrated suspension ( 10'° CFU/mL) 
Viscous suspension ( 1 % methylcellulose) 
• Initial pressure increase before first swallowing movement 
• Pressure increase in steps of 5 kPa, up to a maximum of 50 kPa 
Rat in a dorsal position in the pressure cabin 
Discussion 
In this study, the development of a physiological rat model for pneumococal otitis media 
is described. It shows that unilateral, intranasal application of a small volume (30 μι) of a 
concentrated, viscous pneumococcal suspension (IO10CFU/mL), in combination with an ambient 
pressure increase in measured steps, results in 100% bilateral otitis media in a rat, provided that 
the rat is kept in a dorsal position during the complete procedure. The development of this model 
is based on a statement of Rosenfeld and Bluestone" that high positive nasopharyngeal pressures 
may result in insufflation of (infected) secretions into the middle ear. Considerations on this 
theme led to the assumption that bacteria, deliberately introduced into the nasopharynx, will be 
transferred to the middle ear cavity (via the eustachian tube) after swallowing, provided that the 
ambient air pressure is higher than the middle ear pressure. This proposed mechanism indeed 
has been confirmed by the observation that intranasally applied Evans blue can be detected in 
the tympanic cavity after increasing the ambient pressure. However, it has also become obvious 
that for the development of a reliable OM model, based on ambient overpressure, additional 
conditions have to be considered. 
The necessity of ambient overpressure in this model is demonstrated by the observation that 
intranasal inoculations of SCPNI9F by itself do not result in OM at ambient atmospheric 
pressure. An adequately functioning eustachian tube apparently prohibits bacteria from entering 
the middle ear cavity under normal circumstances. Others23 did show that when ambient pressure 
is increased pressure equilibration between nasopharynx and tympanic cavity is achieved by 
swallowing. As the eustachian tube will open transiently during a swallowing movement, air 
will flow towards the middle car until pressure equilibrium is reached. Consequently, it seems 
plausible that a bacterial suspension that is introduced through a cannula close to the entrance 
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of the eustachian tube will simultaneously be insufflated into the middle car cavity. Considering 
that in the experiments of the present study pressure is increased under controlled conditions 
with consecutive steps of 5 kPa until a maximum of 50 kPa is reached, insufflation will occur 
repeatedly and bacteria may be gradually pushed further up into the eustachian tube. Pressure 
steps of 5 kPa were chosen because these were shown to avoid pathological changes in the 
tympanic membrane, i.e. vascular dilations and haemorrhages. 
The maximum pressure used in our study differs from data collected by Kringlebotn24 but is 
in accordance with those of Sato et al.-15 Kringlebotn reported that the mean pressure causing 
rupture of tympanic membranes in Norwegian cattle is 39.5 kPa. In contrast, Sato et al. show 
that tympanic membranes of rats and guinea pigs are capable of withstanding a pressure increase 
up to 100 kPa (max) without rupturing, but haemorrhages are inevitable. Haemorrhages in the 
tympanic membranes of the rats in the present study could be avoided by limiting the maximum 
pressure to 50 kPa. 
It is of crucial importance that the initial pressure increase is generated before the animal regains 
consciousness. Only then, a reliable induction of OM is possible. This may be explained by 
the observation that without immediate pressure increase, the rat starts swallowing as soon 
as it awakens while ambient pressure is still equal to the middle ear pressure, resulting in the 
translocation of the bacterial suspension into the oesophagus and stomach. 
Occasionally, bilateral intranasal inoculations were found to result in respiratory problems, 
probably due to tracheal obstruction. This could be avoided by unilateral inoculations of 30 μ ι 
with higher bacterial concentrations. Despite adjustments in the protocol, the induction of 
OM was not yet reliable, being sometimes unilateral and sometimes bilateral. For this reason, 
methylcellulose was added to the bacterial suspension, considered to enhance bacterial adhesion 
to the nasopharyngeal epithelium. In addition, the position of the rat in the pressure cabin was 
changed to a dorsal position, because this is likely to direct the bacterial suspension close to both 
eustachian tube openings. Finally, these adjustments led to a reliable model of bilateral OM with 
an induction rate of 100%. Culture of the middle ear effusions yielded only pncumococci which 
indicates that the intranasally inoculated bacterial suspension was insufflated into the tympanic 
cavity. 
Conclusion 
In conclusion, this rat model represents a physiological model for bilateral pneumococcal OM 
that is suitable for studying its pathogenesis. Because of the absence of invasive techniques, it 
will be particularly useful to investigate the immunological aspects of OM, including the effects 
of vaccination. 
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Summary, conclusions and future perspectives 





Otitis media is a multifactorial, infectious disease in which the delicate balance between host 
defence and colonizing (commensal) microorganisms is disturbed. Dysfunction of the eustachian 
tube (ET) also plays an important role in the pathogenesis of this disease, since it is very likely 
the porte d'entrée to the middle ear cavity for pathogens. At the same time the ET is responsible 
for the drainage of waste products originating from the tympanic cavity. The contributions of 
the various factors in the pathogenesis of otitis media is unclear. This thesis describes a series of 
studies conducted to obtain further insight in several pathogenetic mechanisms leading to otitis 
media. Streptococcus pneumoniae (pneumococcus) was selected for several experiments since 
this bacterium is the major bacterial pathogen involved in otitis media. 
In Chapter 2 an overview of the state of the art in (pneumococcal) otitis media research 
illustrates that due to the availability of new techniques an increasing number of pneumococcal 
features are being identified that contribute to the pathogenesis of otitis media. Consequently, 
knowledge of pneumococcal-host interactions is increasing. Furthermore, recent studies provide 
strong indications that biofilm formation may play a role in the development, chronicity as well 
as recurrence of otitis media. 
In the study described in Chapter 3, the genetic rclatedncss of pneumococci concurrently 
present in middle ear effusion, nasopharynx and/or oropharynx in patients with otitis media is 
established. Both AOM and OME patients were included in the study. Bacteria derived from 
these different locations most likely originate from the nasopharynx, since this easily colonized 
zone is open to the environment and includes the orifices of the ETs. The genetic relatedness 
of pneumococci in nasopharynx and middle ear provides further evidence for the hypothesis 
that the pathogenesis of otitis media implies a translocation of bacteria from the nasopharynx 
into the middle ear cavity via the ET. Furthermore, the results of this study indicate that biofilm 
formation may play a role in otitis media with effusion (OME). 
The study described in Chapter 4 demonstrates that antigenic as well as non-antigenic substances 
entering the tympanic cavity are able to induce otitis media in rats. These observations take 
the edge off the term 'otopathogens' and emphasize the role of the ET as "porte d'entrée" for 
microorganisms. Yet it remains remarkable that a selected group of bacteria and viruses (including 
pneumococci, Haemophilus influenzae, Moraxella catarrhalis and respiratory viruses) appears 
to be quite capable of by-passing the defence mechanisms of the ET, as may be deduced from the 
high prevalence of these microorganisms in middle ear effusions. Possibly these microorganisms 
can benefit from environmental factors in the ET facilitating their translocation into the middle 
ear cavity and/or multiplication. An alternative explanation may be that these microorganisms 
arc well equipped in winning the microbial competition prior to colonization of the nasopharynx 
and tubal entrance. Further studies are needed to unravel these aspects. 
The study described in Chapter 5 was conducted to test whether the administration of surfactant 
results in an improvement of the ventilation and clearance function of the ET. The results of the 
experiments with rats reveal that exogenous surfactant reduces the closing forces of the 
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ET significantly, even in these otologically healthy animals, but does not have an effect on 
the mucociliary clearance. Additional investigations are needed to further assess the effect of 
surfactant. In a new study a group of animals with an impaired ET function should be included. 
Furthermore, the properties of endogenous surfactant should be analysed. 
The study described in Chapter 6 demonstrates that heparan sulfate and chondroitin-4 sulfate 
arc exploited by pncumococci as receptors in the initial phase of binding to host epithelium. The 
exact structure and number of all nasopharyngeal glycoconjugate receptors for pncumococci 
remains to be determined, although it is already known from other studies that pncumococci 
additionally utilize specific carbohydrate sequences of glycolipids for binding. It is likely that 
prevention or detachment of pneumococcal adhesion at an early stage may prevent colonization 
and subsequently pneumococcal otitis media. To realize this, nasopharyngeal administration of 
receptor analogues such as a cocktail of specific carbohydrates including glycosaminoglycans, 
may be used as an anti-adhesive agent for pncumococci in order to prevent otitis media. This 
may be considered to be a mild strategy, since it is unlikely that carbohydrates arc toxic or 
immunogenic because they are normal constituents of tissues and body fluids. 
In Chapter 7 the development of a novel, non-invasive rat model for otitis media is described. 
This model utilizes small pressure changes, generated in a pressure cabin under controlled 
conditions, as driving force for the transfer of bacteria (intranasally administered) from the 
nasopharynx into the middle ear cavity resulting in bilateral otitis media. At the same time this 
model reconfirms the hypothesis that otitis media is induced by microorganisms originating from 
the nasopharynx. In this novel animal model neither invasive techniques nor biochemical agents 
are applied. Therefore it is well suited to investigate immunological aspects of otitis media, 
including the effects of vaccination. 
Conclusions 
• Genetic relatedness between pncumococci derived from middle ear and nasopharynx 
from either OME or AOM patients provides evidence for a common pnemococcal 
origin. This pneumococcal source is likely to be located in the nasopharynx. From this 
area bacteria may be translocated via the ET into the tympanic cavity. There they may 
induce otitis media. 
• The discrepancy between the low percentage of pncumococci that are cultured from 
middle ear effusions of OME patients and the relatively large amount of pneumococccal 
DNA established by PCR is indicative of the involvement of biofilm in OME. 
Antigenic as well as non-antigenic substances arc capable of eliciting an inflammatory 
response in the middle car cavity. Hence, it is likely that any substance that reaches the 
middle ear cavity may give rise to the development of otitis media. 
• Administration of exogenous surfactant is able to reduce the closing forces of the 
ET. Therefore, this may be a promising intervention in the improvement of the ET 
function. 
• Heparan sulfate and chondroitin-4 sulfate, both present in the epithelial cell surfaces of 
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the respiratory mucosa of the host, arc exploited as receptors by pneumococci and other 
microorganisms (i c Haemophilus influenzae and several viruses) These observations 
open up new perspectives for the development of novel strategics to prevent otitis media 
Administration of receptor analogues may be used to prevent adherence of pneumococci 
(as well as several other microorganisms) to the mucosa of the host 
• The development of a novel non-invasive rat model for otitis media provides unique 
possibilities to study immunological aspects of otitis media, including the effects of 
vaccination 
• In the presence of potential pathogens in the nasopharynx, pressure differences may 
contribute to the development of otitis media 
Future perspectives 
Future research that may contribute to the development of strategies to prevent otitis media may 
be focussed on 
The role of biofilm in the pathogenesis of otitis media 
• The role ot viruses (especially influenzavirus, RSV, parainfluenza, rhinovirus and 
coronavirus) as well as the effect of interactions between viruses and bacteria in the 
pathogenesisis of otitis media 
• The identification of specific features of the eustachian tube that contribute to the 
development of otitis media 
• The identification of specific as well as general features of microorganisms associated 
with otitis media 
• Studies to elucidate whether specific molecules in mucosal epithelial cells arc used by 
different microorganisms for attachment to the host 
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Samenvatting 
Otitis media (middenoorontsteking) is een infectieziekte, die met name veel bij kinderen 
voorkomt Verschillende factoren spelen een rol in de Pathogenese van deze aandoening De 
twee belangrijkste zijn waarschijnlijk een met-adequate afweerreactie tegen binnendringende 
virussen en bacteriën, en een niet goed functionerende buis van Eustachius (BvE) Gedacht 
wordt dat de BvE voor ziektekiemen de port d'entree naar het middenoor is Dit is bovendien 
de weg waarlangs afvalproducten afgevoerd worden die afkomstig zijn van het middenoor Hoe 
de Pathogenese van otitis media precies verloopt is met helemaal duidelijk Dit proefschrift 
bevat de beschrijving van een aantal (experimentele) onderzoeken die zijn uitgevoerd om hier 
meer inzicht in te krijgen In een aantal experimenten is gebruik gemaakt van Stieptococcus 
pneumoniae (pneumokok) omdat deze bacteriesoort vaak in middenooreffusies van patiënten 
met otitis media wordt aangetroffen 
Hoofdstuk 2 biedt een overzicht van de stand van zaken betreffende het huidige wetenschappelijk 
onderzoek op het gebied van otitis media en belicht de rol die Pneumokokken spelen in het ontstaan 
van deze aandoening Door toedoen van nieuwe technieken blijken er steeds meer specifieke 
pneumokokken-eigenschappen ontdekt te worden die van belang zijn bij middcnoormfecties 
Ook kunnen de interacties tussen gastheer en pneumokok meer in detail worden bestudeerd Uit 
recent gepubliceerde onderzoeken kan geconcludeerd worden dat biofilmvorming mogelijk een 
rol speelt bij chronische en steeds weer terugkerende otitis media Een biofilm kan ontstaan als 
micro-organismen, die zich bijvoorbeeld aan slijmvlies gehecht hebben, zelf slijm gaan produceren 
tijdens de vermemgvuldigingscycli volgend op het hechtingsproces Op de hcchtingsplaats 
ontstaat een dunne, glibberige laag die bestaat uit een "leef-werkgemeenschap" van micro-
orgamsmen die volledig is ingebed in een zelf geproduceerde slijmlaag Deze slijmlaag biedt de 
micro-organismen bescherming tegen zowel afweerstoffen die door het lichaam geproduceerd 
worden, als tegen antibiotica Uit onderzoek blijkt dat (afval)stoffen geproduceerd door de 
micro-organismen in de biofilm, via microkanaaltjes in de slijmlaag naar het oppervlak worden 
afgevoerd en zodoende een chronische of terugkerende ontsteking van het omringende weefsel 
kunnen veroorzaken 
In hoofdstuk 3 wordt het onderzoek beschreven waarin genetische (clonale) verwantschap 
aangetoond wordt tussen Pneumokokken die bij patiënten met otitis media op hetzelfde tijdstip 
zijn aangetroffen zowel in de bovenste luchtwegen als in het middenoor Voor dit onderzoek 
werden van elke patient Pneumokokken verzameld uit middenooreffusie, nasopharynx en/of 
oropharynx (onderdelen van de neus- respectievelijk keelholte) Aan dit onderzoek hebben zowel 
kinderen meegedaan die otitis media met effusie (OME) hadden (vocht achter het trommelvlies), 
als kinderen met acute otitis media (AOM) (acute middenoorontsteking) In de nasopharynx, 
die in verbinding staat met de buitenwereld, komen verschillende bactenesoorten en soms 
ook virussen voor In deze ruimte monden de linker en rechter BvE uit De in dit onderzoek 
aangetoonde genetische (clonale) verwantschap tussen Pneumokokken uit de nasopharynx en 
Pneumokokken uit het middenoor vormt een bevestiging van de hypothese dat micro-organismen 
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die een rol spelen bij ontstaan van otitis media afkomstig zijn uit de nasopharynx, van waaruit ze 
via de BvE naar het middenoor kunnen worden getransporteerd 
Verder doen de resultaten van dit onderzoek vermoeden dat biofilmvorming een rol speelt in 
otitis media met effusic Biofilmvorming kan echter met met zekerheid vastgesteld worden bij 
patiënten met otitis media Om dit te kunnen onderzoeken zouden er namelijk meerdere 
middenoorslijmvliesbiopten per patient genomen moeten worden op verschillende plaatsen in het 
middenoor Dit is om ethische redenen met uitvoerbaar Biofilmonderzoek is eventueel mogelijk 
als er mucosaal onderzoeksmateriaal beschikbaar gesteld wordt door patiënten die bijvoorbeeld 
een radicale middenoorresectie moeten ondergaan 
Het onderzoek dat in Hoofdstuk 4 beschreven wordt toont aan dat substanties van zowel antigene 
als met-antigcne aard die het middenoor bereiken, in staat zijn otitis media te veroorzaken Dit 
betekent dat otitis media met alleen door "otopathogenen" veroorzaakt wordt, zoals nogal eens 
wordt aangenomen Toch zijn er bepaalde groepen bacteriën (Pneumokokken, Haemophilus 
influenzae MoiaxeUa catairhalis) en respiratoire virussen (RSV en rhinovirus) die opvallend 
vaak in middcnooreffusics worden aangetroffen Kennelijk zijn met name deze micro-organismen 
bijzonder goed in staat om de afweermechanismen van de BvE te weerstaan Ook kan het zijn dat 
juist deze micro-organismen bepaalde eigenschappen van de BvE weten te benutten waardoor 
ze op eenvoudige wijze naar het middenoor getransporteerd kunnen worden of waardoor zij 
geprikkeld worden tot vermenigvuldiging Een andere verklaring zou kunnen zijn dat zij de 
juiste eigenschappen bezitten om de onderlinge strijd te winnen die in de nasopharynx en de 
tuba-opening gevoerd wordt tussen micro-organismen, voorafgaand aan kolonisatie Er is meer 
onderzoek nodig om hier uitsluitsel over te krijgen 
Het effect van exogeen surfactant op de ventilatie- en klanngsfunctic van de BvE is onderzocht 
bij gezonde ratten en wordt beschreven in Hoofdstuk 5 Endogeen surfactant wordt geproduceerd 
en uitgescheiden door het epithecl van de BvE Het heeft een oppervlaktespanning verlagende 
werking en speelt mogelijk ook een rol bij de afweer tegen micro-orgamsmcn Uit de resultaten 
van de beschreven experimenten blijkt dat gebruik van exogeen surfactant in het middenoor 
resulteert in een significante afname van de druk die nodig is om de BvE te openen Er is echter 
geen effect op de klanngsfunctic van het middenoor aangetoond, in tegenstelling tot wat wel 
eens door anderen gesuggereerd is Aanvullend onderzoek is nodig om het effect van surfactant 
op de BvE verder in kaart te brengen 
Het onderzoek dat in Hoofdstuk 6 beschreven wordt toont aan dat specifieke glycosaminoglycanen 
(te weten héparine, heparan sulfaat en chondroitine 4-sulfaat) die aangetroffen worden in het 
slijmvhesepitheel van de nasopharynx, door Pneumokokken benut kunnen worden als receptor 
bij de start van het hcchtingsproccs aan de gastheer Ook specifieke suikercomponenten 
behorend tot de glycohpiden van de celmembraan zijn bij de pneumokokkenhechting betrokken, 
zo is aangetoond door anderen Deze kennis kan gebruikt worden om nieuwe therapeutische 
strategieën te ontwikkelen ter voorkoming en genezing van otitis media Als het bijvoorbeeld 
lukt om de hechting van Pneumokokken aan het slijmvhesepitheel van de nasopharynx te 
verhinderen dan kan er geen kolonisatie plaatsvinden Bijgevolg zal er ook geen otitis media 
ontstaan De mogelijkheid bestaat dat het intranasaal toedienen van rcceptoranalogen dit kan 
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bewerkstelligen. Hiervoor zou een cocktail van carbohydraten gebruikt kunnen worden, bestaande 
uit bovengenoemde glycosaminoglycancn en specifieke suikercomponenten van glycolipiden. 
Mocht deze methode effectief blijken te zijn, dan zou dit een zeer patiëntvriendelijke aanpak 
zijn, gezien het feit dat carbohydraten niet toxisch of immunogeen zijn. 
In Hoofdstuk 7 wordt de ontwikkeling van een nieuw, nict-invasicf rattenmodel voor otitis 
media beschreven. In dit model worden kleine drukverschillen, opgewekt in een drukcabinc, 
als stuwende kracht gebruikt om bacteriën (die via de neus in de nasopharynx zijn aangebracht) 
vanuit de nasopharynx naar het middenoor te verplaatsen waardoor er bilateraal otitis media 
ontstaat. De werking van dit model toont aan dat otitis media kan worden veroorzaakt door 
bacteriën die afkomstig zijn uit de nasopharynx. Ook bij mensen kunnen drukverschillen een 
rol spelen bij het ontstaan van otitis media. Met name tijdens vliegen en duiken is het heel 
goed mogelijk dat micro-organismen die aanwezig zijn in de nasopharynx, naar het middenoor 
geperst worden, met alle gevolgen vandicn. 
In tegenstelling tot wat gebruikelijk is in de bestaande modellen worden in dit nieuwe diermodcl 
geen invasievc technieken of biochemische agentia gebruikt. Het is daarom uitermate geschikt 
om de immunologische aspecten van otitis media te bestuderen (bijvoorbeeld om de effecten van 
pncumokokkenvaccinatics na te gaan). 
Conclusies 
De genetische (clonale) verwantschap tussen Pneumokokken uit het middenoor en de 
nasopharynx van zowel de OME als AOM patiënt, aangetoond in dit proefschrift, bewijst 
dat de bacteriën in deze regio afstammen van een gemeenschappelijke bron, die in de 
nasopharynx gelegen lijkt te zijn. Via de BvE kunnen de bacteriën naar het middenoor 
worden getransporteerd, waar ze otitis media kunnen veroorzaken. 
Het lage percentage bacteriën dat uit middenooreffusies van OME patiënten gekweekt 
wordt en de relatief grote hoeveelheid Pneumokokken DNA die in diezelfde effusics 
wordt aangetroffen, doen vermoeden dat er sprake is van biofilmvorming in het 
middenoor van deze patiënten. 
Antigene, maar ook nict-antigene substanties zijn in staat om een inflammatoire response 
op te wekken in het middenoor. Waarschijnlijk is elke substantie die het middenoor 
bereikt in staat om otitis media te veroorzaken. 
Toediening van exogeen surfactant verlaagt de passieve openingsdruk van de BvE. 
Wellicht is het locaal toedienen van surfactant een goede aanpak om de werking van de 
BvE te verbeteren. 
• Heparine, heparan sulfaat en chondroitine 4-sulfaat kunnen door zowel Pneumokokken 
als door andere micro-organismen (waaronder Haemophilus influenzae en verschillende 
virussoorten) als receptoren worden gebruikt om zich aan epitheliale cellen van de 
respiratoire mucosa van de gastheer te hechten. Deze bevindingen kunnen dienen als 
aangrijpingspunt voor het ontwikkelen van nieuwe methodes ter voorkoming van otitis 
media. Met behulp van receptoranalogen kan wellicht de hechting van Pneumokokken 
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(en andere micro-organismen) aan de mucosa van de gastheer verhinderd worden. Het 
uitblijven van nasopharyngeale kolonisatie zal ertoe leiden dat het ontstaan van otitis 
media voorkomen wordt. 
Het nieuwe, niet-invasieve rattenmodcl voor otitis media verschaft de mogelijkheid om 
immunologische aspecten van otitis media te onderzoeken, waartoe ook de effecten van 
vaccinatie behoren. 
Als de atmosferische druk hoger is dan de druk in het middenoor kan bij aanwezigheid 
van potentiële pathogenen in de nasopharynx, otitis media onstaan. 
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Dankwoord 
Dit proefschrift zou niet compleet zijn zonder een woord van dank aan de mensen die op de een 
of andere manier (zowel wetenschappelijk als prive) hebben bijgedragen aan het tot stand komen 
van dit boekje Zonder mensen tekort te willen doen zal ik me beperken tot het noemen van hen 
die een bijzondere rol hebben gespeeld 
Professor dr Κ Graamans (promotor) U hebt in de afgelopen jaren vooral vanaf de zijlijn 
meegekeken Zo veel mogelijk probeerde u bij de werkbesprekingen aanwezig te zijn, maar 
dat lukte vaak niet vanwege andere verplichtingen In de periode waarin het op schrijven 
aankwam was u echter, ondanks uw volle agenda, steeds bereid om op zeer korte termijn op­
en aanmerkingen te plaatsen Ik heb dat erg gewaardeerd Verder heb ik uw waardering voor 
de middenooronderzoeklijn als een steun in de rug ervaren, vooral op momenten waarop ik 
ietwat in de verdrukking dreigde te raken tussen de overdaad aan binncnooronderzoekers op de 
afdeling 
Professor dr E A M Sanders (promotor) Het maakte verschil uit als jij erbij was tijdens de 
KNOOP-bijeenkomsten Dat kwam met alleen door je betrokkenheid, je deskundigheid, je 
bereidheid om mee te denken met anderen en je snelle manier van analyseren, maar ook door de 
manier waarop je commentaar leverde zorgvuldig, positief en opbouwend Tocnje tot hoogleraar 
benoemd werd hoopte ik datje mijn tweede promotor zou willen worden Ik vind het een eer 
dat je daar inderdaad toe bereid was Graag wil ik je bedanken voor de substantiële bijdrage 
die je geleverd hebt aan het tot stand komen van enkele artikelen in dit boekje Door jouw 
wetenschappelijk inzicht, creativiteit en enthousiasme heeft het eindproduct dat ik afgeleverd 
heb duidelijk 'meerwaarde' gekregen 
Dr H J A J Curfs (co-promotor) Net in de periode waarin JIJ voorjezelf het hoofdstuk Medische 
Microbiologie probeerde afte sluiten en je in ban begon te raken van lonkanalen en stoornissen 
in de homeostase van binnenoorvloeistoffen kwam ik van tijd tot tijd de pret voor je bederven 
met mijn pneumokokkenpenkelen Niettemin was je bereid om op dagen waarop ik een groot 
experiment had gepland 's morgens voor dag en dauw Pneumokokken voor me aan te enten, 
zodat ik bij aankomst meteen aan de slag kon Bedankt daarvoor en ook voor het feit datje me, 
na het ontploffen van de drukkamer, manhaftig terzijde hebt willen staan toen ik met knikkende 
kmeen aan het eerste experiment met het prototype van de zelf ontworpen drukcabine begon 
Het gaf me net het vereiste zetje 
Het lezen van mijn eerste artikel moet vanwege mijn 'steenkolen' Engels voor jou een gruwel 
zijn geweest Toch ben je zonder een krimp te geven aan het schaven en polijsten gegaan Met 
terugwerkende kracht bied ik je mijn excuses aan 
Prof dr ir G A Z\z\\m\<ì(KNOOP-4) Alshoofdprojectleidervan KNOOP-4hebje mijn onderzoek 
van het begin tot het einde gevolgd Ik vond je een zeer betrokken en daadkrachtige projectleider 
en voorzitter Daarnaast wist je waar nodig brandjes te blussen en mensen te stimuleren Wat ik 
niet zal vergeten is dat je op enkele cruciale momenten voor mij in de bres gesprongen bent Ik 
heb dat bijzonder gewaardeerd en ben je daar zeer dankbaar voor 
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Niels van Heerbeek (KNOOP-4) Gedurende enkclcjaren wasje mijn buurman op de researchgang 
en de enige KNOOP-cr in het ziekenhuis Dat schiep een band Het was een genot om met jou 
kritische noten te kraken De dagen die we samen hebben doorgebracht op het dierenlab vlogen 
altijd voorbij In een heel andere setting heb ik met bewondering toegekeken hoeje de KNOOP-
kinderen die op controle kwamen aan het slikken en snuiven kreeg De keren dat ik de metingen 
van je heb overgenomen bleek het succespercentage beduidend minder te zijn Jammer datje 
zo snel promoveerde en uit mijn gezichtsveld verdween1 
Masja Straetemans, Selma Wicrtsema en Sonja van Oosterhout (KNOOP-CTS) Omdat ik 
met mijn dierexperimenteel werk de appendix van het KNOOP-4 project vormde, stond ik 
letterlijk en figuurlijk wat verder van jullie af Toch hebben wc heel wat (meestal) prettige uren 
samen doorgebracht aan verschillende tafels Vaak hadden de KNOOP-4 bijeenkomsten een 
Bourgondisch tintje Steeds opnieuw werd er cen reden gevonden om op (zelfgcbakken) taart te 
trakteren of moest er nodig weer eens samen gegeten worden (Toch zijn wc allemaal redelijk op 
gewicht gebleven ) De cen na de ander is inmiddels uitgevlogen, maar dankzij de e-mail blijft 
er contact Selma, JIJ bent straks de hekkensluitster Veel succes1 
Bert van der Baan, Joost Engel, Koen Ingels (co-autcur), Ger Rijkers (co-auteur) en Anne Schilder 
Als projectgroepleden van KNOOP-4 hebben jullie allemaal, zij het op heel verschillende 
manieren, een bijdrage geleverd aan dit proefschrift waarvoor ik jullie hartelijk wil bedanken 
Geert Poelen, Dcbby Smits, Helma Janssen en overige SPFcrs (CDL) Het eerste jaar op jullie 
afdeling werd gekenmerkt door een opeenvolging van frustrerende gebeurtenissen Toen de bron 
van alle ellende uiteindelijk gevonden was bleek een volledige herstart van mijn onderzoek 
onvermijdelijk te zijn Ondanks het uitzonderlijke en bewerkelijke protocol dat er vanaf toen 
gevolgd moest worden heb ik jullie nooit horen mopperen Bedankt voor de wijze waarop jullie, 
in goede en in slechte tijden, steeds voor mij hebben klaar gestaan 
De hulp en medewerking die ik van verschillende afdelingen binnenshuis en buitenshuis kreeg, 
vond ik werkelijk heel bijzonder Ik denk daarbij aan de EM-grocp van de afdeling Celbiologie, 
met name Huib Croes en Mietske Wijers, de Mycologie researchgroep van de afdeling Medische 
Microbiologie, met name Hein van der Lee, het laboratorium van de afdeling Dermatologie, met 
name Evert Lamme, de DNA-diagnostickgroep van de afdeling Medische Microbiologie van 
het Cathenna-Wilhclminaziekcnhuis, met name Jacques Meis, Come Klaassen, Hanneke van 
Haren, Corina Bens en Maaike de Ruiter en de pneumokokkengroep van het laboratorium van 
de afdeling Kindergeneeskunde van de Erasmus Universitair Medisch Centrum, met name Peter 
Hermans en Marcel Sluijter Ik ben jullie allemaal heel erg dankbaar voor jullie hulp 
Theo Peters, JIJ hebt het onderzoeksproces als mijn kamergenoot van zeer nabij meegemaakt, 
met alle ups en downs die daarbij hoorden Ik hoop dat we nog lang in de gelegenheid zullen zijn 
om op van die speciale momenten onze stoelen naar elkaar toe te draaien om even stoom af te 
blazen of om gewoon even bij te praten 
Els Verbcck-Camps niet alleen bedankt voor de vele coupes die je van al dat weerbarstige 
materiaal gesneden hebt, maar ook voor de morele ondersteuning 
(Ex)-gebruikers van het Researchlab Natasja Lieuwes, Leon Onessen, Pieter Buma, Diny 
Versieyen, Sanne van der Donk, Tony van Tienen en Navin Ramrattan Bedankt voor alle 
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verleende hand- en spandiensten en voor de (on)zinnige gesprekken tijdens de thee (waar we 
tegenwoordig bijna nooit meer aan toekomen). 
Mijn paranymfen Huib Croes en Theo Hafmans: Bijna vanaf mijn eerste wankele schreden in de 
research waren wij "partners in crime." Dat is zo gebleven, ook nu we al jaren op verschillende 
laboratoria werkzaam zijn. Altijd kon ik bij jullie terecht voor hulp en steun of een luisterend 
oor als mijn onderzoek weer eens vastzat, of als ik meende beren op de weg te zien. Het vangnet 
dat jullie op die manier voor mij gevormd hebben, heeft me voor misstappen behoed. Jullie zijn 
goud waard! 
Familie en vrienden, dankzij het feit dat jullie er voor mij waren, lukte het me aardig om op 
gezette tijden (wetenschappelijke) beslommeringen van me af te schudden. Jullie wisten me 
te verleiden tot een Argentijnse tango, een avondje sauna of tennis, een fikse wandeling, een 
klassiek concert of een heerlijke maaltijd. Op die manier hebben jullie me ervoor behoed dat ik 
transformeerde tot een work-aholic. Ik ben jullie daar zeer dankbaar voor. 
Mama, aan jou en papa heb ik een goed voorbeeld gehad. Dankzij het feit dat jullie me geleerd 
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Curriculum vitae 
Edith L.G.M. Tonnaer werd geboren op 10 november 1949 te Roermond. Na aldaar in 1969 haar 
diploma HBS-B behaald te hebben aan het St. Ursula Lyceum, begon zij aan de studie Biologie 
aan de Katholieke Universiteit te Nijmegen. In 1976 studeerde zij af en was achtereenvolgens 
werkzaam als laboratorium medewerkster op de afdeling Cytohistologie (Prof.dr. C R Jeusalem) 
van de Medische Faculteit (K.UN), de afdeling Orthopedie (Prof. dr. T. J.J.H. Slooff) en de 
afdeling KNO (prof. dr. P. van den Broek; vanaf 2000 prof. dr. K. Graamans) van het Academisch 
Ziekenhuis Nijmegen/ UMC St. Radboud. Samen met een aantal andere onderzoekers is zij vanaf 
oktober 1999 tot oktober 2004 verantwoordelijk geweest voor het KNOOP-4 project, waarin 
onderzoek werd verricht naar de etiologie van recidiverende otitis media met effusie bij kinderen. 
Dit project komt voort uit een samenwerkingsverband tussen de afdeling Epidemiologie en 
KNO van het UMC St. Radboud te Nijmegen en de afdeling Immunologie van het Wilhelmina 
Kinderziekenhuis-UMCU te Utrecht. Vanaf 1 januari 2005 is zij als onderzoekster verbonden aan 
het Cl-project. In dit project wordt naar mogelijkheden gezocht om de werking van cochleairc 
implantaten te optimaliseren. 
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